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ABSTRACT

EXPERIENCES AND PERCEPTIONS OF RURAL POSTPARTUM WOMEN WITH
SUBSTANCE USE DISORDERS INCLUSIVE OF OPIOIDS REGARDING THEIR
CARE

By
Debra L. Kramlich
August 2017

Dissertation supervised by Rebecca Kronk, PhD, MSN, CRNP
Perinatal opioid use and neonatal withdrawal continue to rise rapidly in the face
of the growing epidemic of opioid addiction in the United States, with rural areas more
severely impacted. Despite several decades of research and development of practice
guidelines, maternal and neonatal outcomes have not improved substantially. This
focused ethnography aimed to address that gap by exploring rural women’s experiences
and perceptions of care to inform development of efficacious, holistic models of care to
improve outcomes for these women and their children. Participant observations, oral
accounts and formal interviews, and artifact review (i.e., health records, any print and
electronic resources provided to the women to support direct care, and media
documentation of the sociopolitical environment influencing the women’s care) were
used to seek answers to the following questions: a) What are the experiences and
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perceptions of women with substance use disorder regarding the care they received
during their pregnancy and through their infants’ hospitalization? and b) How have their
experiences supported or inhibited their ability to bond with their baby?
Thirteen participants were recruited through perinatal outpatient practices and
hospital social workers. Their personal accounts, reinforced by participant observation
and artifact review, uncovered three domains with underlying themes: access (service
availability, distance/geographic location, transportation, provider
collaboration/coordination, physical and emotional safety), care of the baby (proximity,
information), and relationships (respect, empathy, familiarity, inclusion, interactions with
care providers). The findings highlight the need for providers and policy makers to
reduce barriers to care related to logistics, stigma, judgment, and lack of understanding of
perinatal addiction.

v

DEDICATION

First, this dissertation is dedicated to the courageous women who shared their
experiences of pregnancy, birth, and recovery. Their stories revealed pain, gratitude, and
hope. I feel honored and humbled that they were willing to open up to me, an outsider
dropping into their lives at a vulnerable time for them. I hope I’ve done their stories
justice.
I also dedicate this dissertation to my family: my husband, David, my four grown
sons and their wives/fiancée, and my seven grandchildren. Their love, support, and belief
gave me the strength to persevere in this journey.

vi

ACKNOWLEDGEMENT

First, I thank my dissertation chair, Dr. Rebecca Kronk. I so appreciated her
optimism, patience, and kind, gentle spirit. Her guidance helped keep me focused and on
track, especially when she would remind me to step back and enjoy the process. I also
thank my dissertation committee members: Dr. Karen Jakub, for her invaluable
knowledge of focused ethnography; Dr. Alison Colbert, for her practical advice and
attention to detail; and Dr. Lenora Marcellus, for her experience, wisdom, and
compassion for women and their babies affected by substance use.
I thank the Kappa Zeta-at-Large Chapter, Sigma Theta Tau International Honor
Society of Nursing, for their financial support of my dissertation study through the Holly
Gimpel Research Grant. I thank the Eastern Maine Medical Center chief pediatrician and
perinatal social workers who took time out of their busy schedules to facilitate
recruitment and answer many questions. Finally, I am grateful for the kinship of my
sisters on this “Gr8 Journey”, my cohort 18 classmates. We did it!

vii

TABLE OF CONTENTS
Page
Abstract .............................................................................................................................. iv
Dedication .......................................................................................................................... vi
Acknowledgement ............................................................................................................ vii
List of Appendices ...............................................................................................................x
CHAPTER 1: Introduction ..................................................................................................1
Background ..............................................................................................................1
Purpose.....................................................................................................................4
Study Aims...............................................................................................................4
Definitions of Key Terms ........................................................................................4
References ................................................................................................................7
CHAPTER 2: Systematic Review of Literature (Manuscript #1) ....................................13
Abstract .................................................................................................................13
Introduction ............................................................................................................15
Methods .................................................................................................................17
Results and Discussion .........................................................................................18
Limitations .............................................................................................................22
Implications and Conclusion..................................................................................22
Suggested Websites ...............................................................................................24
References .............................................................................................................25
Table .....................................................................................................................28
Flow Diagram .......................................................................................................33

viii

CHAPTER 3: Originally Approved Study Proposal .........................................................34
Specific Aims .........................................................................................................34
Background and Significance ................................................................................36
Preliminary Work...................................................................................................46
Research Design and Methods ...............................................................................46
Protection of Research Participants .......................................................................60
References ..............................................................................................................62
CHAPTER 4: Methodological Challenges (Manuscript #2) ............................................86
Abstract .................................................................................................................86
Background ...........................................................................................................87
Study Purpose and Design ....................................................................................93
Recruitment Challenges ........................................................................................95
Recruitment Facilitators ........................................................................................99
Conclusions and Lessons Learned .......................................................................100
References ...........................................................................................................103
CHAPTERS 5 and 6: Findings and Discussion (Manuscript #3) ...................................113
Abstract ................................................................................................................113
Background ..........................................................................................................114
Design and Method ..............................................................................................120
Findings ...............................................................................................................127
Discussion ...........................................................................................................143
References ...........................................................................................................154

ix

LIST OF APPENDICES
Page
Appendix A: Potential Participant Characteristics ............................................................78
Appendix B1: Fact Sheet – Hospital Personnel .................................................................79
Appendix B2: Fact Sheet - Family.....................................................................................81
Appendix C: Observation Guide ........................................................................................83
Appendix D: Interview Guide ............................................................................................84
Appendix E: Medical Record Data Extraction Guide........................................................85
Appendix F: Media Artifact References ..........................................................................174
Appendix G: Data Analysis Process Flowchart ...............................................................179
Appendix H: MCN Permission to Reuse Published Article ............................................180

x

CHAPTER 1
This document is structured in accordance with the Duquesne University School of
Nursing Manuscript Option #2 dissertation format. Chapter 1 provides an overview for this
dissertation study, briefly summarizing the background, purpose, and specific aims, as well as
definitions of key terms. Chapter 2 is a published systematic review. Chapter 3 is the originally
approved proposal for the study and is written in the future tense. Chapter 4 is published
manuscript describing methodological challenges encountered during participant recruitment for
this study. Chapters 5 and 6 comprise the final study findings and discussion in manuscript form
for submission for publication to Qualitative Health Research.
Background
The United States is facing a rapidly growing epidemic of opioid addiction. Since 1999,
sales of prescription opioid analgesics and the rate of unintentional opioid-related overdose
deaths have more than quadrupled, with women being affected more than men, disrupting the
health, social, and economic welfare of the country (American Society of Addiction Medicine
[ASAM], 2016; Senate Caucus, 2014; United States Department of Health and Human Services
[HHS], 2016). The opioid epidemic has been accompanied by a sharp rise in perinatal exposure
to opioids and subsequent increase in the incidence of neonatal abstinence syndrome (NAS), a
term applied to a constellation of symptoms characterized by dysregulation and hyperirritability
of the central and autonomic nervous, respiratory, and gastrointestinal systems (Ko et al., 2016;
Patrick et al., 2015; Pryor et al., 2017; Tolia et al., 2015). Data show disproportionately higher
rates of perinatal substance use in rural areas, with three states (Maine, Vermont, and West
Virginia) experiencing greater than tenfold increases and NAS incidence rates > 30 per 1,000
hospital births (Ko et al., 2016; Villapiano, Winkelman, Kozhimannil, Davis, & Patrick, 2016).
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Women living in rural areas tend to have lower rates of early initiation of prenatal care,
higher rates of pregnancy complications, and higher infant mortality rates than their urban
counterparts, even when controlling for substance use (American College of Obstetricians and
Gynecologists [ACOG], 2014). Additionally, socioeconomic disparities, such as poverty,
unemployment, and low education level, which are more prevalent in rural areas, are associated
with late or inadequate prenatal care and higher rates of adverse birth outcomes (ACOG, 2014;
Blumenshine, Egerter, Barclay, Cubbin, & Braverman, 2010; Phillippi, 2009). Access to prenatal
care in rural areas is often hindered by lack of resources (finances, transportation, childcare,
availability); in women with substance use disorders, these barriers are compounded by fear of
judgment and losing child custody (Phillippi, 2009).
Perinatal substance use directly impacts both the woman and her offspring, and research
over the past several decades from a variety of perspectives has attempted to identify modifiable
factors associated with negative outcomes, with inconclusive results. Studies have failed to
demonstrate a predictable correlation between duration, timing, and total cumulative dose of
prescription opioids on incidence or severity of NAS; variability in presentation of NAS
symptoms is likely multifactorial (Desai et al., 2015; Kraft, Stover, & Davis, 2016; Stover &
Davis, 2015). Studies focusing on care of the newborn with NAS have been equally
inconclusive. This is likely due, in part, to wide variations in care of opioid-exposed newborns
and lack of standardized NAS treatment (Bogen, Whalen, Kair, Vining, & King, 2016; Kelly et
al., 2016).
A growing body of evidence is demonstrating the benefits of early and adequate prenatal
care, harm reduction approaches, and promotion of maternal-infant bonding. Pregnancy is often
the motivation a woman needs to seek treatment for substance use disorders, which provides an
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opportunity for health and social care providers to engage women (Krans, Cochran, & Bogen,
2015). Principles of harm reduction aim to ameliorate the negative impact of substance use and
related risks, such as poverty, interpersonal violence, psychiatric comorbidity, nutritional
deficiencies, inadequate health care, and stressful life experiences (Sutter, Gopman, & Leeman,
2017). Such a philosophy requires care providers to set aside their own opinions and emotions
regarding substance use and instead focus on re-engagement of the woman moving forward
(Bartlett et al., 2013). Harm reduction approaches combined with comprehensive care models
(antenatal care, social services, and substance use treatment) are showing promising results
(Goodman, 2015; Marcellus, MacKinnon, Benoit, Phillips, & Stengel, 2015; Nathoo et al., 2015;
Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, & Boyajian, 2013).
Increased parental presence at the newborn’s bedside has been shown to increase rates of
breastfeeding, reduce need for pharmacologic treatment, shorten duration of treatment, and
decrease length of hospital stay (Abrahams et al., 2010; Hodgson & Abrahams, 2012; Holmes et
al., 2016; Howard et al., 2017; Hünseler, Brückle, Roth, & Kribs, 2013; McKnight et al., 2016;
Newman et al., 2015). Historically, opiate-exposed newborns have been admitted for
observation, monitoring, and treatment in the neonatal intensive care unit (NICU) (Newman et
al., 2015). This environment, while supporting medical management of newborns with NAS, can
be stressful due to the increased stimulation and may also discourage parental presence, thus
increasing the need for pharmacotherapy (Maguire, 2014; Newman et al., 2015). Infants may be
safely observed and cared for in same room with their mothers; these newer rooming-in models
can promote maternal-infant bonding and improve outcomes (McKnight et al., 2016). Variation
in study designs and models of care, as well as the complex matrix of variables explored in those
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studies, obscure efforts to draw conclusions with respect to best practices (Bagley, Wachman,
Holland, & Brogly, 2014).
Purpose
The problems associated with perinatal substance use disorders persist despite decades of
research. The voice of pregnant and parenting women with substance use disorders has been
minimally included in prior studies as evidenced by the relatively limited number of qualitative
studies. The purpose of this study was to explore rural women’s experiences and perceptions of
care they received through their pregnancy and postpartum hospitalization, as well as
experiences that may have influenced infant bonding.
Study Aims
The specific aim of the current study was to address the identified gaps in knowledge
regarding care of this vulnerable population through the personal accounts of the women. Of
particular interest was the role of nursing in care delivery. Ethnographic methods (Hammersley
& Atkinson, 2007; Spradley, 1979, 1980) were used to seek answers to the following research
questions:
1. What are the experiences and perceptions of rural women with substance use disorder
regarding the care they received during their pregnancy and through their infants’
hospitalization?
2. How have their experiences supported or inhibited their ability to bond with their baby?
Definitions of Key Terms
Addiction: Various definitions of addiction are noted in the literature. Maternal addiction, in
particular, has been defined as “a complex, progressive behavioral pattern having
biological, psychological, medical, sociological, and behavioral components”
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(Kaltenbach & Finnegan, 1992, p. 262). The behavioral focus of these definitions has
perpetuated the assumption that addiction is a “moral failing or lack of individual selfcontrol” (Bartlett, Brown, Shattell, Wright, & Lewallen, 2013, p. 349). The American
Society of Addiction Medicine (2015) defines addiction as “a primary, chronic disease of
brain reward, motivation, memory, and related circuitry” (p. 3) with cycles of relapse and
remission. This definition emphasizes the bio-psycho-social-spiritual nature of the
disease which needs to be addressed within a multifactorial framework and will,
therefore, be used for this study.
Care: Defined by the mother and included, but was not limited to, access to and coordination
and integration of services provided by nurses and other health care professionals, social
workers, substance abuse and mental health providers, and other support agencies.
Opioid use: Defined for the purpose of this study as use of illegal opioid drugs, such as heroin,
misuse of legally available pain relievers such as oxycodone and hydrocodone, and/or use
or misuse of medications prescribed for medication-assisted treatment, such as
buprenorphine and methadone.
Rural: The Federal Office of Rural Health Policy defines rural areas as non-Metropolitan
(Metropolitan is defined as a core urban area of 50,000 or more population) and RuralUrban Commuting Area codes of 4-10 (higher numbers signify lower population density)
(Health Resources & Services Administration, 2017).
Substance use disorder: The recurrent use of alcohol and/or drugs which causes clinically and
functionally significant impairment, such as health problems, disability, and failure to
meet major responsibilities at work, school, or home. According to the DSM-5, a
diagnosis of substance use disorder is based on evidence of impaired control, social
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impairment, risky use, and pharmacological criteria (Substance Abuse and Mental Health
Services Administration, 2015).
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CHAPTER 2
This is a non-final version of an article published in final form in Kramlich, D., & Kronk, R.
(2015). Relational care for perinatal substance use: A systematic review. MCN: The American
Journal of Maternal/Child Nursing, 40(5), 320-326. doi: 10.1097/NMC.0000000000000160.
Wolters Kluwer Health Lippincott Williams & Wilkins©
http://journals.lww.com/mcnjournal/pages/default.aspx

Relational Care for Perinatal Substance Use: A Systematic Review
Debra Kramlich, MSN, RN, CCRN and Rebecca Kronk, PhD, MSN, CRNP
Abstract
Objective: The purpose of this systematic review of the literature is to highlight published
studies of perinatal substance use disorder that address relational aspects of various care delivery
models to identify opportunities for future studies in this area.
Method: Quantitative, qualitative, and mixed-methods studies that included relational variables,
such as health care provider engagement with pregnant women and facilitation of maternal-infant
bonding, were identified using PubMed, Scopus, and EBSCO databases. Key words included
neonatal abstinence syndrome, drug, opioid, substance, dependence, and pregnancy.
Results: Six studies included in this review identified statistically and/or clinically significant
positive maternal and neonatal outcomes thought to be linked to engagement in antenatal care
and development of caring relationships with health care providers.
Implications/Conclusion: Comprehensive, integrated multidisciplinary services for pregnant
women with substance use disorder aimed at harm reduction show a trend toward positive
results. Evidence exists that pregnant women’s engagement with comprehensive services
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facilitated by caring relationships with health care providers may improve perinatal outcomes.
Gaps in the literature remain; studies have yet to identify the relative contribution of multiple
risk factors to adverse outcomes as well as program components most likely to improve
outcomes.
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Relational Care for Perinatal Substance Use: A Systematic Review
Recently published data show a nearly threefold increase in the prevalence of perinatal
substance use disorders (SUD) and subsequent fetal exposure to addictive substances in the
United States in the 10-year span from 2000 to 2009, contributing to poor short-term perinatal
and long-term developmental outcomes and creating a significant and costly public health issue
(D'Apolito, 2009; McGlone, Mactier, & Weaver, 2009; O'Donnell et al., 2009; Patrick et al.,
2012). Women with SUD face numerous impediments to accessing available resources for
recovery and parenting support (Fraser, Barnes, Biggs, & Kain, 2007), further complicated by
rural healthcare disparities, specifically those related to poverty (Lander et al., 2013). Early and
adequate prenatal care has been shown to reduce risks of prematurity and low birthweight,
factors known to increase neonatal mortality and morbidity and often related to maternal
substance use (Burns, Mattick, Lim, & Wallace, 2007; El-Mohandes et al., 2003; Partridge,
Balayla, Holcroft, & Abenhaim, 2012). The level of engagement, defined in part by
personalization of care and relationships, rather than access to services may contribute to
improved outcomes (Docherty, Bugge, & Watterson, 2012).
According to the World Health Organization (WHO, 2014), indigenous women such as
Native Americans in the United States, or aboriginals in Australia or Canada, in particular, have
been exposed to generations of emotional, psychological, and physical trauma related to
dislocation and loss of culture, resulting in even higher rates of SUD. These women also
experience poorer access to health care. The prevalence of unplanned pregnancies,
unemployment, poverty, co-occurring psychiatric disorders, intimate partner violence, coaddicted partners, history of parental abuse and addiction, and rural residence seems to be higher
among pregnant women with SUD (Denton, Adinoff, Lewis, Walker, & Winhusen, 2014; Lander
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et al., 2013; Unger, Metz, & Fischer, 2012). Variables such as lower socioeconomic status, rural
isolation, poor nutritional status, environmental pollution, and domestic violence may contribute
to negative maternal and fetal outcomes independent of substances used and irrespective of
medication-assisted treatment (MAT) (Baldacchino, Arbuckle, Petrie, and McCowan, 2014;
Gilligan et al., 2009; Gray, Edwards, Schultz, & Miranda, 2014; Greig, Ash, & Douiri, 2012;
Han & Stewart, 2014; Kent, McClure, Zaitchik, & Gohlke, 2013).
Evidence from the above-referenced studies indicates that negative perinatal outcomes
involving substance use may be attributable to multiple and interrelated variables. Recently, the
WHO (2014) published recommendations for care of pregnant women with SUD based on five
overarching principles:


prioritizing prevention



ensuring access to prevention and treatment services



respecting patient autonomy



providing comprehensive care



safeguarding against discrimination and stigmatization

Examples of such approaches to address this issue within a context of harm reduction, health
promotion, and service coordination, which include the promotion of woman-health care
provider (HCP) and mother-infant relationships, are beginning to show some promise (Benoit et
al., 2014; Meyer et al., 2012; Wright, Schuetter, Fombonne, Stephenson, & Haning, 2012).
Literature addressing various facets of perinatal SUD has been published in journals
targeting distinct yet diverse audiences, such as perinatal, pediatric, substance abuse, psychology,
and sociology practitioners, challenging widespread dissemination of study findings. Such
diversity and the sheer volume of studies conducted over the past several decades preclude a
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comprehensive overview of the literature. The purpose of this systematic review of the literature
is to highlight studies of perinatal SUD that included HCP-mother-infant relational perspectives
within various care delivery models to identify opportunities for future studies in this area as
outlined in the WHO guidelines.
Methods
A systematic computer-assisted search of the English-language literature published
within the past 10 years was conducted using keyword searches in the PubMed, Scopus, and
EBSCO databases. Keyword search terms and Boolean combinations of neonatal abstinence
syndrome, drug, opioid, substance, dependence, and pregnancy were used to identify relevant
articles, including primary studies, systematic reviews, general review articles and case studies,
and full-text dissertations and theses. Reference lists of each article were then scanned for
additional primary sources.
The initial search yielded 305 English-language articles published within the past 10
years. Based on review of abstracts, 88 articles were screened for further review, yielding 38
articles limited to quantitative, qualitative, and mixed-methods studies that included relational
variables, such as HCP engagement with pregnant women and facilitation of maternal-infant
bonding (see Figure 1). The articles were read in full to evaluate the extent to which relational
variables were examined and considered important factors in outcomes. The 32 excluded articles
focused primarily on variables such as type and amount of MAT or were secondary analyses of
large datasets. The six studies included in this review (summarized in Table 1) identified
statistically and clinically significant positive maternal and neonatal outcomes thought to be
linked to engagement in antenatal care and development of caring relationships with HCP.
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Results and Discussion
Designs
Several of the studies used qualitative methods to explore women’s perspectives of the
impact of comprehensive, integrated multidisciplinary services for pregnant women with SUD
(Morris, Seibold, & Webber, 2012; Motz, Leslie, Pepler, Moore, & Freeman, 2006; Racine,
Motz, Leslie, & Pepler, 2009). Motz et al. (2006) also provided quantitative results of
retrospective clinical data collected over a 10-year span to confirm the success of the services as
described by the women. Meyer et al. (2012) retrospectively identified their sample and analyzed
data extracted from medical records. Buckley, Razaghi, and Haber (2013) stated their cohort was
followed prospectively during pregnancy, yet data from hospital records were analyzed
retrospectively. Only one of the studies followed and collected data prospectively on a cohort of
women using objective clinical data rather than self-report (Wright et al., 2012).
Sample Characteristics
Socioeconomic and demographic characteristics of the samples in the six studies are
outlined in Table 1. Demographic data were not quantitatively reported in one study (Morris et
al., 2012), and socioeconomic status was missing in another study (Meyer et al., 2012). Three
samples reported indigenous status which has been found to contribute independently to
substance use and poorer perinatal outcomes (Buckley et al., 2013; Motz et al., 2006; Racine et
al., 2009; Wright et al., 2012). Methods of reporting pregnancy status varied from nulliparity to
gravidity and parity means and ranges. Such disparate methods of reporting subject
characteristics make comparisons across studies challenging.
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Intervention/Program Characteristics
All six studies described some form of multidisciplinary service provision that the
authors identified as contributing to more positive perinatal outcomes; however, the composition
and mechanism of delivery of those services varied widely. Buckley et al. (2013) simply stated
that a multidisciplinary team of specialist nursing and medical personnel provided
comprehensive medical, obstetric, addiction, and psychosocial care. Meyer et al. (2012)
described the evolution of their program from community-based services with minimal
interaction to a multidisciplinary team that included social work, visiting nurses, physicians
(addiction, obstetrics, and neonatology), and child protective services. These services were not
center-based but information was freely shared among the providers. Meyer et al. (2012) state
that services were coordinated across agencies and that most of the women and newborns
received care within a single clinic, yet case management is not explicitly described. Neither
program declared a particular guiding model or theoretical framework.
The other three programs were identified as outpatient multidisciplinary clinics with
various service provision models. Mothercraft’s Breaking the Cycle (BTC) Pregnancy Outreach
Program in Canada was described as a comprehensive, integrated, early intervention program
with services delivered collaboratively through a single-access model (Motz et al., 2006; Racine
et al., 2009). The services, many described as facilitated or provided by nurses, include
individual and group addiction treatment, parenting programs, child care, child developmental
services, health/medical services, mental health counseling, case management, parent-infant
counseling, home visitation, pregnancy outreach, and support around instrumental needs such as
food, clothing, and transportation. The Transitions Clinic (TC), located in a hospital for women
in Melbourne, Australia, delivers comprehensive care by a multidisciplinary team, with the first
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point of contact being two midwives (Morris et al., 2012). Antenatal and postnatal care,
childbirth education, psychosocial and financial support, and addiction treatment is provided,
with referral to community agencies as needed. Both programs stage interventions according to
the Transtheoretical Model of behavior change (TTM). They use harm reduction principles,
which focus on ameliorating the risks associated with SUD through early engagement in prenatal
care, encouragement of health-promoting behaviors (improved nutrition, dental care, and
physical activity), support for reduction in use of all substances (alcohol, tobacco, and drugs),
and promotion of social and community support. The BTC program also identified several
theoretical frameworks as key to the success of the program: relational theory, attachment
theory, and developmental theory.
These studies described integrated services for SUD and perinatal care with a particular
focus on opioid use due to its prevalence in those populations. A comprehensive perinatal,
addiction, and social services clinic for pregnant women with SUD in Hawaii, also based on
harm reduction principles, was evaluated for the impact on perinatal outcomes in pregnant
women using methamphetamines (MA), which is particularly problematic in Hawaii and the
western United States (Wright et al., 2012). Unlike MAT for opioid use, there are no approved
medications for treatment of MA addiction; therefore, abstinence is the ultimate goal of therapy.
This clinic also employed the Transtheoretical Model and Stages of Change Model. Wright et al.
(2012) listed the services provided in this freestanding clinic but not the specific providers;
therefore, nursing’s role in the model could not be confirmed.
Program Outcomes
Due to differences in definition and measurement of outcome variables, it is nearly
impossible to compare the results of the six studies. None of the quantitative studies shared
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common maternal variables, and those that reported similar neonatal outcome variables used
dissimilar measurement criteria. Pregnancy complications, such as cesarean birth, were reported
in four of the studies (Buckley et al., 2013; Meyer et al., 2012; Motz et al., 2006; Wright et al.,
2012), but no distinctions were made between planned and unplanned cesareans nor comparisons
made with the general obstetric population. Antenatal visits were quantified using a variety of
methods; only one of the studies (Meyer et al., 2012) reported a statistically significant increase
in the number of prenatal visits over the study period (p = .006), whereas the other studies only
reported mean numbers of prenatal visits. No description of the quality of those visits was
provided. Neonatal outcomes were typically reported as gestational age at birth, birthweight,
incidence of neonatal abstinence syndrome requiring pharmacologic treatment, length of hospital
stay, and discharge home with mother. The quantitative studies identified that neonatal outcomes
were not independently related to maternal substance use. Other factors, such as treatment
engagement and psychosocial and demographic characteristics, were predictive of improved
outcomes. Table 1 specifically enumerates those reported outcomes.
Perhaps the qualitative data are more indicative of positive program outcomes. Women
engaged in comprehensive, integrated multidisciplinary programs identified the attitudes of the
HCP and the development of collaborative relationships as essential for healing and their
engagement in care. Morris et al. (2012) found that the initial contact between the women and
HCP was crucial to establishment of a collaborative relationship regardless of TTM stage.
Similarly, Motz et al. (2006) noted that respect and empathy shown by the outreach workers
toward the women were foundational to successful relationships, which in turn fostered sustained
positive relationships between the women and their infants, other mothers, friends, and family
members (Racine et al., 2009).
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Limitations
Various models of comprehensive programs providing integrated services for SUD and
perinatal care have been described in the literature. Differences in service structure and location,
modes of care delivery, client demographics, and methods of program evaluation create
challenges to comparison of outcomes as well as identification of program components that may
have contributed to success. The programs described in this review were structured differently,
from a monthly meeting of members of a multidisciplinary needs assessment team of community
and hospital-based HCPs following hospitalization for initiation of treatment (Meyer et al.,
2012), to single-access community-based programs (Motz et al., 2006; Racine et al., 2009), to
specialized multidisciplinary clinics (Buckley et al., 2013; Morris et al., 2012; Wright et al.,
2012). The composition of the multidisciplinary teams varied across the studies; one study did
not describe specific services or HCPs (Buckley et al., 2013). Support services, such as
transportation and child care, were provided by several of the programs (Motz et al., 2006;
Racine et al., 2009; Wright et al., 2012), and financial incentives were explicitly described in one
study (Wright et al., 2012). Four of the programs were located in major metropolitan areas
(Buckley et al., 2013; Morris et al., 2012; Motz et al., 2006; Wright et al., 2012), with three
developed in countries with universal health care (Buckley et al., 2013; Morris et al., 2012; Motz
et al., 2006). Control groups for comparison were lacking in all the studies.
Implications and Conclusion
Comprehensive, integrated multidisciplinary services for pregnant women with SUD
aimed at harm reduction are showing positive results, but gaps in the literature remain. Women
living in remote rural geographic areas with fewer resources who may experience greater
obstacles to accessing services are grossly underrepresented in the current studies. Research
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regarding the impact of marijuana on maternal and neonatal outcomes is inconclusive; as more
states legalize marijuana for recreational use, more studies will be needed to accurately inform
practice (Miller, 2012). The recent passage of a law in Tennessee explicitly criminalizing drug
use during pregnancy is concerning. Prior studies have demonstrated the negative impact of such
laws related to the reluctance of women to seek treatment and prenatal care to avoid prosecution
without the intended benefits (Lester, Andreozzi, & Appiah, 2004). This resurgence of the “War
on Drugs” will need to be followed carefully (Lester et al., 2004, p. 3).
Studies have yet to identify the relative contribution of multiple risk factors to adverse
outcomes as well as program components most likely to improve outcomes. The strength of the
evidence supporting the WHO recommendations (2014) ranges from conditional to strong, with
the quality of the evidence rated as low to very low, indicating substantial gaps in the evidence.
World Health Organization research priorities include improved descriptions of current practices,
standardized outcomes and measurement of data, qualitative studies on ethical issues, and studies
in low-income populations. The WHO recommendations offer a framework for future studies
that may strengthen the quality evidence to support comprehensive, integrated, relationshipbased care models.

Suggested Clinical Nursing Indications:
1. Nurses caring for pregnant women with SUD should promote and facilitate
comprehensive, integrated, multidisciplinary services to reduce barriers to care.
2. Collaborative relationships between nurses and pregnant women with SUD, based on
respect and empathy, can promote healing and engagement in care as well as facilitate
mother-infant bonding.
3. Harm reduction principles, rather than insistence on abstinence, promote understanding
of the context of substance use and can facilitate treatment engagement and reduce
barriers to care related to stigma and shame.
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Suggested Websites:
World Health Organization Guidelines for the management of substance use and substance use
disorders in pregnancy:
http://www.who.int/substance_abuse/activities/pregnancy_substance_use/en/
Substance Abuse and Mental Health Services Administration TIP 51: Substance Abuse
Treatment: Addressing the Specific Needs of Women:
http://store.samhsa.gov/product/TIP-51-Substance-Abuse-Treatment-Addressing-theSpecific-Needs-of-Women/SMA14-4426
Maine Center for Disease Control and Prevention, Snuggle ME Guidelines for Screening and
Treatment of Pregnant Women with Substance Use Disorders:
http://www.maine.gov/dhhs/mecdc/population-health/cshn/
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Study
Buckley,
Razaghi,
& Haber
(2013)

Table 1: Evidence for Relational Perspectives of Care Delivery for Pregnant Women
with Substance Use Disorder
Description of Study & Sample Significant Results &
Limitations &
Characteristics
Major Findings
Recommendations
Retrospective data analysis of a
No statistically significant differences
Data collected
prospective study of pregnant
in frequency of LBW or prematurity.
prospectively by
substance-using women to
NAS occurrence comparable across all clinical staff during
document predictors of neonatal
groups.
routine care, then
outcomes.
analyzed
Methadone only group more likely to
retrospectively.
Records of 183 methadone or
retain custody of their newborns at
heroin using pregnant women
discharge (p < .001).
Missing data, small
cared for by specialist services in
sample size,
Attendance at antenatal visits
two major teaching hospitals in
gestational age at
independently predicted odds of LBW, first appointment
the Sydney South West Area
Health Services area of Australia prematurity, and discharge status;
not recorded.
therefore, engagement in antenatal care
(107 methadone, 15 heroin, 61
reduced likelihood of negative
Need more research
both)
outcomes for the mother-infant dyad.
into socioeconomic
Mean age ranged from 25.5 years
factors, quality of
Care provided by a multidisciplinary
for heroin-only users to 29 years
healthcare
team thought to be crucial to treatment interactions, and
for methadone-only users;
engagement.
gravidity/parity ranges were
longer family
reported as 0-21/0-8, with means
follow-up.
of 3/1
Nearly ¼ of women were of
indigenous origin (indigenous
population of Australia is 2.5%);
less than 10% were employed,
and 85% claimed their principle
source of income as government
benefits or dependent on others

Meyer et
al. (2012)

Retrospective record review of
women treated for opioid
dependence during pregnancy to
determine whether improved
access to medication assisted
therapy in the general population
with improved coordination of
ancillary services for pregnant
women improved perinatal
outcomes

As access to treatment in the general
population expanded, the # of women
receiving treatment increased,
proportion of women receiving interim
substitution therapy decreased (p <
.001), gestational age at initiation of
treatment decreased (p < .001), &
proportion of women receiving
treatment before pregnancy increased
(p < .001).

149 women/151 neonates
delivered at one tertiary care
center acting as a referral
hospital for a rural region in
Vermont between 2000 & 2006

Infants delivered to mothers in a
treatment program had improved
birthweight z score compared with
those receiving interim substitution
therapy (p = .007). % of infants
requiring pharmacologic therapy for
NAS decreased (p = .03).
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Transition to
coordinated services
occurred
concurrently with
expansion of MAT
access in the general
public.
Unable to
differentiate
between impact of
improved access to
MAT, improved
coordination of
services, or effect of
buprenorphine as an
MAT option.

Mean age over the 5 data
collection points was 24.7 to 26
years; 5-16% were nulliparous
(differences over the data
collection periods not statistically
significant)

Proportion of infants discharged to the
care of the mother & remaining in
maternal care at 1 year improved both
over time (p = .03; p = .004) & with
treatment within a treatment program
(p < .001; p = .004).

Demographic data regarding SES
not reported

No data on women
who left treatment
before delivery >
reasons for
premature
withdrawal.
No data on
polysubstance use.
No mention of
quality of
relationships
between HCP &
pregnant women.

Morris,
Seibold,
& Webber
(2012)

Critical ethnography to explore
extent to which a
multidisciplinary specialist clinic
focused on harm minimization
meets the needs of chemically
dependent women. Stage of
recovery identified according to
the Trans-Theoretical Model
(TTM)
20 chemically dependent
pregnant women at a major
metropolitan women’s hospital in
Australia
Demographic data not
quantitatively reported; women
described as experiencing family
instability, family history of drug
& alcohol abuse, childhood
sexual abuse, chemically
dependent partners, and dual
diagnoses of addiction & mental
illness.

Multiple factors influence development
& maintenance of chemical
dependency: family instability, family
history of drug & alcohol abuse,
childhood sexual abuse, having a
chemically dependent partner, dual
diagnosis of substance use and mental
illness.
Attitudes of individual staff members,
particularly midwives, were key to the
way women responded to care and the
evolution of collaborative relationships
between HCP & pregnant women.
Initial contact between women & HCP
crucial to establishment of relationship
regardless of TTM stage.

Some services felt to
be lacking: family
therapists trained in
mental health with
drug & alcohol
qualifications, and
postnatal support for
women able to
parent children.
Need quantitative
studies to examine
perinatal outcomes
related to
engagement in such
care.

Women sometimes felt secondary to
unborn child & resented being seen as
“baby incubators”.
Women felt discounted in decisionmaking.
Physical space not facilitative of
communication.
Supportive relationships developed
over time; most participants (15/20)
reported positive benefits & desire to
maintain engagement with the clinic
program.

Motz et
al. (2006)

Part 3 of this comprehensive
report describes the evaluation of
the Breaking the Cycle (BTC)
program in Toronto, Canada,

Statistical significance of outcomes
was not reported; trends toward
improvement in numerous perinatal
health indicators and outcomes noted
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Limitations: selfreport, limited
objective substance

using quantitative & qualitative
methods.
BTC is a comprehensive,
integrated, single-access early
intervention program for
pregnant women with substance
use disorders based on principles
of harm reduction, relational
theory, developmental theory,
and attachment theory.
Approaches & interventions used
TTM/Stages of Change model &
Motivational Interviewing (MI)
Data collected from 160 highrisk women engaged in the BTC
Pregnancy Outreach Program
(CPNC) April 2001-May 2005;
data collected on 1170 mothers
accessing BTC 1995-2005
Mean age 28 years; average of
one prior pregnancy (range 0-10)

when the Pregnancy Outreach Program
was added, including:









use data, no control
group.

Lower gestational age at
initial engagement in care
Greater access to & use of
supportive health & treatment
services
More likely to complete
treatment
Retained custody of children
Maintained substance use
recovery at discharge
Greater maternal-infant
attachment
More normal child
development

Respect & empathy shown by
Pregnancy Outreach Worker (POW)
foundational to successful
relationships.

Sociodemographic characteristics
of participants extensively
described: briefly, 13% identified
as indigenous (as compared with
4.3% of the general population);
46% experienced homelessness;
37% had no income & 49% were
receiving general public
assistance; significantly higher
rates of food insecurity; 70% had
≤ 10 years of schooling; 60%
were single.
Racine et
al. (2009)

Qualitative study to describe
experiences of pregnant
substance-involved women
engaged in a comprehensive,
integrated, single-access early
intervention program (Breaking
the Cycle Pregnancy Outreach
Program - CPNC) based on
principles of harm reduction,
relational theory, developmental
theory, and attachment theory.

Promotion of relational capacity in
pregnant & parenting women involved
with substance use; non-judgmental,
caring attitudes & behaviors of
outreach workers; being with other
similar women; healing through the
power of relationship.
Rich data gleaned from the stories of
the women engaged in this outreach
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See above; this
study gleaned
qualitative data
regarding aspects of
the program likely
to engage and retain
women in the
program.
Quantitative studies
with control groups
in similar
populations would

Three focus groups with total n =
19 former high-risk clients of the
BTC CPNC program in Toronto,
Canada (demographics described
above in Motz et al. study); a
subset of a larger mixed-methods
program evaluation study
comparing BTC with CNPC

Wright et
al. (2012)

Examine outcomes of
implementation of a harmreduction model for clinical care
of substance using pregnant
women; used Stages of Change
Model & MI
132 pregnant women (47%
indigenous) with past or present
history of addiction cared for in a
clinic offering comprehensive
perinatal & social services in an
urban, academic medical center
Hawaii, compared with a
representative cohort of women
(22% indigenous) delivering at
the same hospital without the
clinic services.

strengthen the
findings

Statistically significantly higher rates
of gravidity & parity, smoking &
methamphetamine use, chronic
medical conditions & native Hawaiian
in clinic cohort (all p < .001); no
statistically significant differences in
pregnancy complications. Predictors of
poor infant outcomes were related to
factors other than drug use (parity,
history of domestic violence, maternal
medical conditions, poor prenatal
care).
Assumed that comprehensive care
delivered using harm-reduction
approaches & motivational incentives
resulted in relatively normal birth
outcomes.

Mean age 28.3 years; gravidity
4.5/parity 2.3
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No control group of
substance-using
pregnant women not
engaged in
comprehensive
services for
comparison.

Included

Eligibility

Screening

Identification

Figure 1: Flow diagram of article selection

Records identified through search of
PubMed, Scopus, and EBSCO databases and
scanned reference lists; English-language,
years 2004-2014
(n = 305 )

Records for further
screening
(n = 88)

Full-text articles further
assessed for eligibility
(n = 38)

Records excluded (general
reports and review articles)
(n = 50)
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CHAPTER 3
Chapter 3 is the dissertation proposal in its original form, presented on November 13, 2014.

Experiences and Perceptions of Postpartum Women with Substance Use Disorders Inclusive of
Opioids Regarding Their Care
Specific Aims
Data show a rapidly increasing prevalence of substance use disorders during pregnancy
and subsequent perinatal exposure to addictive substances, resulting in poor short-term fetal and
neonatal and long-term developmental outcomes and creating a significant and costly public
health issue worldwide (D'Apolito, 2009; McGlone, Mactier, & Weaver, 2009; O'Donnell et al.,
2009; Patrick et al., 2012). Excessive prenatal substance exposure may result in negative birth
outcomes, including low birthweight and prematurity, and cause neonatal abstinence syndrome
in infants, including respiratory problems, feeding difficulties, and seizures (Walton-Moss,
McIntosh, Conrad, & Kiefer, 2009). More is becoming known about the long-term effects of
drug exposure, including delayed cognitive and motor development (Mactier, 2013) and
increased child protective involvement (Lean, Pritchard, & Woodward, 2013), placing an even
greater burden on health care, social welfare, and foster care services.
Maine has the highest rate of prescription opiate drug misuse in the country (Hayes &
Brown, 2012); a report published in 2010 by the Substance Abuse and Mental Health Services
Administration (SAMHSA) noted Maine’s per capita rate of non-heroin opiate addiction in 2008
was 386 per 100,000, compared to 45 per 100,000 for the Unites States and 131 for New
England. The percentage of newborns with neonatal abstinence syndrome discharged from
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Maine hospitals rose from 0.1% in 2000 to 2% in 2009 and those numbers continue to increase;
927 babies were born affected by drugs in Maine in 2013, more than 7% of all births (Maine
DHHS, 2014). Despite increasing attention on this problem and evidence-based
recommendations (Dow et al., 2012; Goettler & Tschudin, 2014; Hudak & Tan, 2012; Jansson,
Velez, & Harrow, 2009; Lucas & Knobel, 2012; Queensland & Neonatal Clinical Guidelines,
2010; Winklbaur et al., 2008), management remains inconsistent, hospital length of stay has not
declined, and expenditures continue to rise. Quantitative and interventional studies have yet to
produce sustained, efficacious improvement in outcomes for these mothers and children
(Milligan et al., 2010). Additionally, societal stigma and lack of resources further contribute to
the negative outcomes for both mother and child (Lander et al., 2013).
Women with substance use disorders continue to face numerous impediments to
accessing available resources for recovery and parenting support (Fraser, Barnes, Biggs, & Kain,
2007). Substance use disorder in women is associated with increased prevalence of mental
illness, histories of physical and sexual abuse, and medical and social problems (Milligan et al.,
2010). Studies have shown that rural healthcare disparities, specifically those related to poverty,
further complicate access to treatment (Lander et al., 2013). This is particularly concerning in
light of findings that protective factors, such as caretaker involvement and family resources, may
moderate the negative effects of substance use on the developing child (Bada et al., 2012). An
exploration of the experiences of women with substance use disorder regarding the care they
have received for pregnancy, parenting, recovery, and psychosocial and economic issues is
necessary to identify unmet needs and determinants of the problem. Since many of the studies
described in the background and significance of the problem have focused on the perinatal
impact of opioid use, the population of interest in the proposed study is defined as women with
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any form of current opioid use (illicit, misuse of prescription opioid medications, medication
assisted treatment) and not excluding use of other substances. The long-term objective, future
development of efficacious interventions to promote successful parenting and decrease the risk
of further trauma to the mother-infant dyad, is contingent upon such understanding.
The specific aim of this study is to begin to bridge the current gap in knowledge
regarding care of this vulnerable population. “Care” will be defined by the mother and may
include, but not be limited to, access to and coordination and integration of services provided by
nurses and other health care professionals, social workers, substance abuse and mental health
providers, and other support agencies. Of particular interest will be the role of nursing in care
delivery. This may be achieved through a qualitative exploration of the following questions:
1. What are the experiences and perceptions of women with substance use disorder, defined
for the purpose of this study as any form of current opioid use while not precluding use of
other substances, regarding the care they received during their pregnancy and through
their infants’ hospitalization?
2. How have their experiences supported or inhibited their ability to bond with their baby?
Background and Significance
Results from the 2013 National Survey on Drug Use and Health found that among
pregnant women aged 15 to 44, 5.4% were current illicit drug users (SAMHSA, 2014). Current
illicit drug use was lower among pregnant women aged 15 to 44 during the third trimester than
during the first and second trimesters (2.4% vs. 9.0% and 4.8%). When stratified by age, the rate
of current illicit drug use was 14.6% among pregnant women aged 15 to 17, 8.6% among women
aged 18 to 25, and 3.2% among women aged 26 to 44. According to data from the Treatment
Episode Data Set (TEDS), while the proportion of substance abuse treatment admissions in
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females aged 15 to 44 years who were pregnant at treatment entry has remained stable between
2000 and 2010, the percentage reporting drug abuse but not alcohol abuse has increased from
51.1% to 63.8% (SAMHSA, 2013).
Of drug exposed newborns, 50% to 90% will experience some degree of neonatal
abstinence syndrome, a term applied to a constellation of symptoms characterized by
dysregulation and hyperirritability of the central and autonomic nervous, respiratory, and
gastrointestinal systems (Sublett, 2013). Symptoms are treated with a combination of
pharmacologic and non-pharmacologic therapies typically requiring specialized care in the
neonatal intensive care unit (NICU) with an average length of hospital stay of 25 days.
A retrospective study conducted by Patrick et al. (2012) found that between 2000 and
2009 the incidence of neonatal abstinence syndrome among newborns in the U.S. increased from
1.20 to 3.39 per 1000 hospital births per year while antepartum maternal opiate use increased
from 1.19 to 5.63 per 1000 hospital births per year. In 2009, newborns with neonatal abstinence
syndrome were more likely than all other hospital births to have low birthweight, have
respiratory complications, and be covered by Medicaid. Mean hospital charges for discharges
with neonatal abstinence syndrome increased from $39,400 in 2000 to $53,400 in 2009. By
2009, 77.6% of charges for neonatal abstinence syndrome were attributed to state Medicaid
programs (Patrick et al., 2012).
Concerns regarding perinatal substance use are not new; literature regarding physician
interest in the effects of drugs and alcohol on women and children dates back nearly three
centuries (Boyd & Marcellus, 2007). Attitudes toward therapeutic and illicit use of substances,
particularly opioids, and approaches to addiction treatment have been shaped by various social,
moral, political, economic, and legal influences. The development of practices and policies
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specifically addressing perinatal substance use has paralleled the evolution of the rights of
women and children, including the unborn fetus. Generally, the women affected by such
decisions have been excluded in the process.
Pregnant and parenting women with substance use disorders present a particular
challenge with regard to problem identification and outcome measurement. Pregnancy and
childbirth are considered normal physiological processes, yet framed by the disease of addiction,
these processes tend to be pathologized and used to punish women for their addictive behaviors
(Boyd & Marcellus, 2007). Salmon (2010) advanced the term reproductive citizenship to
describe the assumption that women have both the ability and responsibility to minimize risk in
their lives during pregnancy and birth. Pregnant and parenting women who use substances have
been thought to be deviant; such moral judgments, stigmatization, and subsequent punitive
policies have resulted in challenges to engagement of these women in the treatment process.
The disease of addiction, particularly maternal addiction, has been defined as “a complex,
progressive behavioral pattern having biological, psychological, medical, sociological, and
behavioral components” (Kaltenbach & Finnegan, 1992, p. 262) and, therefore, needs to be
addressed within a multifactorial framework. Maternal substance use disorder does not occur in a
vacuum, and it would be a disservice to describe and explain addictive behaviors solely on the
basis of individual factors. One study found multiple biopsychosocial predictors of treatment
outcomes in women with substance use disorders and identified the importance of careful
assessment of these factors when designing outpatient and residential treatment programs for
these women (Comfort, Sockloff, Loverro, & Kaltenbach, 2003). As noted by Suchman, Pajulo,
and Mayes, (2013), “pregnant and parenting women who suffer from substance use disorders
present a very complex and difficult challenge to those concerned with improving the
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environment of care for their children” (p. 185). These women often report family histories of
substance abuse which suggests both genetic and environmental determinants of substance
misuse. They also experience higher rates of violence, trauma, and subsequent post-traumatic
stress disorder, as well as psychiatric comorbidity. Native American women, in particular, have
been exposed to generations of emotional, psychological, and physical trauma related to
dislocation and loss of culture, resulting in even higher rates of substance use disorder (Bohn,
2003; SAMHSA, n.d.). The lack of positive role models and personal coping skills further
contribute to substance use disorders in women with these multiple, complex challenges. It
seems a majority of the published studies of antenatal substance use disorders and the impact on
the women and infants have failed to account for this complexity and have targeted limited
aspects of the problem.
Maternal Medication-Assisted Treatment and Neonatal Outcomes
Perinatal substance use directly impacts two constituencies, the woman and her offspring,
and therefore the problem has been examined from a variety of perspectives. Numerous
quantitative studies have been conducted to identify factors regarding maternal drug use which
may be predictive of neonatal outcomes, such as the type and amount of medication-assisted
treatment for opioid use. Several retrospective studies associated higher doses of maternal
methadone dose with higher incidence of neonatal abstinence syndrome as well as duration of
neonatal abstinence syndrome treatment (Dryden, Young, Hepburn, & Mactier, 2009; Lim,
Prasad, Samuels, Gardner, & Cordero, 2009). These findings contradicted those of other studies,
which reported no such correlation (Berghella et al., 2003; McCarthy, Leamon, Parr, & Anania,
2005; Pizarro et al., 2011; Seligman et al., 2008). One prospective cohort study also concluded
that the incidence and duration of neonatal abstinence syndrome was not affected by methadone
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dose (Cleary et al., 2012). McCarthy, Leamon, Stenson, and Biles (2008) noted that infants of
women who began methadone treatment prior to conception had better outcomes compared with
those whose mothers began treatment mid-pregnancy.
Similar conflicting results have been noted in studies comparing maternal methadone and
buprenorphine medication-assisted treatment. Several studies suggested improved neonatal
outcomes, such as lower incidence and severity of neonatal abstinence syndrome, in infants
exposed to buprenorphine as compared with methadone exposure (Binder & Vavrinkova, 2008;
Coyle et al., 2012; Gaalema et al., 2012; Kakko, Heilig, & Sarman, 2008; Salisbury et al., 2012).
Other studies found no such differences (Jones et al., 2010; Lejeune, Simmat-Durand, Gourarier,
& Aubisson, 2006; Welle-Strand et al., 2013). Patel and colleagues (2013) noted no difference in
neonatal abstinence syndrome expression when comparing infants exposed to buprenorphine to
those exposed to illicit opiates. The concomitant use of illicit substance, as well as alcohol and
tobacco, with medication-assisted treatment seems to confound the results of these studies
(Blandthorn, Forster, & Love, 2011; Kaltenbach et al., 2012).
Many of the aforementioned studies have been retrospective reviews of clinical data or
secondary analyses of data from larger studies. Two multicenter prospective studies from which
much data have been drawn, the Maternal Lifestyle Study (Bauer et al., 2002) and the Maternal
Opioid Treatment: Human Experimental Research (MOTHER) study (Jones et al., 2010), have
generated a great deal of discussion and debate among the scientific and practice communities.
Findings of these studies regarding severity of neonatal abstinence syndrome relative to type and
dose of maternal substance or medication-assisted treatment have been conflicting. In fact,
Winklbaur-Hausknost and colleagues (2013) found that maternal treatment resulting in reduced
illicit drug use throughout pregnancy had no influence on neonatal outcomes in two separate
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studies. In a systematic review and meta-analysis, Cleary and colleagues (2010) found no clear
link between neonatal abstinence syndrome severity and methadone dose. Similarly, Thajam,
Atkinson, Sibley, and Lavender (2010) found no correlation between amount and type of fetal
opioid exposure and neonatal abstinence syndrome expression in eight of the 10 studies they
reviewed. It may be concluded that a singular focus on drug type and dose fails to account for the
complex array of factors contributing to neonatal outcomes.
Maternal-Infant Bonding
Literature regarding neonatal abstinence syndrome care has been equally inconclusive.
Sublett (2013) noted that, despite extensive research on pharmacologic therapy and
recommendations by the American Academy of Pediatrics, no clear answer to standardized
neonatal abstinence syndrome treatment has been established. This is likely due, in part, to
failure to establish a definite relationship between maternal drug type and dose and severity of
neonatal withdrawal symptoms (Dryden et al., 2009; Sublett, 2013; Velez, Jansson, Schroeder, &
Williams, 2009). It appears that factors other than maternal medication-assisted treatment, such
as maternal-infant bonding, have greater influence on neonatal outcomes. One study conducted
by Saiki, Lee, Hannam, and Greenough (2010) showed that care of neonatal abstinence
syndrome infants on the postpartum unit with their mothers, rather than in the NICU, resulted in
shorter duration of treatment and hospital stay.
Backes and colleagues (2012) found that infants discharged home on a methadone
weaning protocol with support from a multidisciplinary team, as opposed to a traditional
inpatient methadone wean, resulted in shorter hospital stays and reduced cost. A retrospective
review conducted in the United Kingdom yielded similar findings (Smirk, Bowman, Doyle, &
Kamlin, 2014). Investigators in both studies noted that breastfeeding rates were significantly
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higher in the home detoxification groups which may have accounted for perceived benefits.
Several studies found that substantial breast milk intake significantly reduced severity of
neonatal abstinence syndrome symptoms, delayed the onset of symptoms, and decreased the
need for pharmacologic treatment (Abdel-Latif et al., 2006; Dryden et al., 2009). These studies
seem to support the conclusion that treatment of the neonatal abstinence syndrome baby should
be provided with the participation of the mother to promote maternal-infant bonding and
breastfeeding (Sublett, 2013). As will be noted, however, engagement of the mothers to establish
a foundation for this bonding has proven challenging.
Maternal Substance Use and Child Maltreatment
According to Smarsh Hogan and Myers (2006), it is commonly believed that mothers
with substance use disorders may place their children at higher risk of maltreatment. While data
suggest an association between maternal substance use disorders and child maltreatment (Walsh,
MacMillan, & Jamieson, 2003), other studies have noted that environmental risks, such as
depression, psychiatric disorders, domestic violence, and lower socioeconomic status may
contribute more significantly to child maltreatment (Nair, Schuler, Black, Kettinger, &
Harrington, 2003; Smarsh Hogan & Myers, 2006). Unfortunately, pregnant women with
substance use disorders tend to face those same problems; studies have shown a higher
prevalence of unplanned pregnancies, unemployment, poverty, co-occurring psychiatric
disorders, intimate partner violence, co-addicted partners, history of parental abuse and
addiction, and rural residence among this population (Denton, Adinoff, Lewis, Walker, &
Winhusen, 2014; Lander et al., 2013; Unger, Metz, & Fischer, 2012).
Early Identification, Engagement, and Treatment Retention
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Early and adequate prenatal care has been shown to mitigate the negative effects of
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning,
2012). Unfortunately, pregnant women with substance use disorders may delay or completely
avoid seeking care due to fears of judgmental or uncivil care provider reactions (Metz, Kochl, &
Fischer, 2012). These fears are not unfounded; evidence has shown continued misunderstanding
and negative attitudes of healthcare providers toward pregnant women with substance use
disorders (Benoit et al., 2014; Fraser et al., 2007; Maguire et al., 2012; Murphy-Oikonen,
Brownlee, Montelpare, & Gerlach, 2010). Socioeconomic constraints and low literacy levels are
additional barriers to treatment engagement (Alto & O'Connor, 2011). While attrition rates for
women who do engage in treatment are reported to be high (Sharon M. Mullins, Suarez,
Ondersma, & Page, 2004), engagement is the first step toward treatment and recovery. Ideally,
comprehensive care for these women would include treatment for the substance use to promote
abstinence and ease withdrawal symptoms, combined with antenatal care and social services to
support parenting success. Pregnancy is often the impetus a woman needs to seek treatment for
substance use disorder, providing an opportunity for health and social care providers to engage
these women.
Studies of early identification, engagement, and treatment retention of pregnant women
using integrated substance abuse and perinatal services are showing potential benefits in the
promotion of maternal-infant bonding (Burns, Mattick, Lim, & Wallace, 2007; Kissin, Svikis,
Moylan, Haug, & Stitzer, 2004; Mayet, Groshkova, Morgan, MacCormack, & Strang, 2008;
Meyer et al., 2012; Mullins, Bard, & Ondersma, 2005; Racine, Motz, Leslie, & Pepler, 2009;
Suchman, Mayes, Conti, Slade, & Rounsaville, 2004; Suchman, Pajulo, DeCoste, & Mayes,
2006; Taylor et al., 2012). Identification of maternal substance use has been challenging. Some
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studies have indicated that universal screening of all women for drugs and alcohol may reduce
socioeconomic and racial disparities, resulting in improved identification (Casper & Arbour,
2013; Eichel & Johannemann, 2014; Roberts & Nuru-Jeter, 2011). Others have questioned the
wisdom of this approach, suggesting that fear of negative consequences may preclude women
from seeking prenatal care (Roberts & Nuru-Jeter, 2010).
A variety of strategies for engagement of pregnant women with substance use disorders
in prenatal care and treatment have been explored. Motivational interviewing (MI) and
motivational enhancement therapy (MET) have been included in studies of prenatal alcohol use
(Osterman & Dyehouse, 2012), treatment utilization in pregnant substance users (Winhusen et
al., 2008), and treatment retention of women with substance use disorders involved with child
welfare (Mullins et al., 2004). Both MI and MET interventions have shown mixed results in
pregnant women. According to Jones and Kaltenbach (2013), MI appears to hold some promise
as part of a comprehensive approach, but more studies are needed to determine if and how it
facilitates behavior change in this population.
Use of behavioral incentives has been explored as a means for engaging and retaining
pregnant women in substance-abuse treatment (Brigham, Winhusen, Lewis, & Kropp, 2010;
Comfort, Loverro, & Kaltenbach, 2000; Hutchinson, Chisholm, Tuten, Leoutsakos, & Jones,
2012; Jones, Svikis, Rosado, Tuten, & Kulstad, 2004; Schottenfeld, Moore, & Pantalon, 2011;
Svikis, Silverman, Haug, Stitzer, & Keyser-Marcus, 2007). Results have been mixed, but it
seems that efficacy is related to the type, amount, timing, and frequency of the incentives as well
as the mechanism of treatment entry (coerced versus voluntary). Trust-building was also found to
be an important component of the intervention.
Harm-Reduction Philosophy
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Decades of failed attempts to require and achieve abstinence in addictive behaviors has
led to development of a harm-reduction philosophy (Boyd & Marcellus, 2007). Harm-reduction
recognizes the relapsing characteristic of substance-misuse, not unlike other chronic diseases,
and is “based on the premise that alcohol and drug addiction and the associated risks can be
placed on a continuum, with the goal being to help the client move along this continuum from
excess to moderation” (Suchman et al., 2013, p. 375). Such a philosophy requires care providers
to set aside their own opinions and emotions regarding relapse and instead focus on reengagement of the woman moving forward. Studies of harm-reduction approaches in Britain, the
Netherlands, and Canada have shown positive outcomes in terms of lower rates of child
protective involvement and withdrawal symptoms in infants (Boyd & Marcellus, 2007). Pilot
studies in the U.S. have shown similar results (Wright et al., 2012). The programs described in
the literature have used a variety of interventions, including integrated prenatal and substance
abuse services and motivational incentives, so it is unclear which aspects of a harm-reduction
approach contribute to outcomes.
Literature Synthesis and Identified Gap
As the literature shows, the problem of maternal substance use and its negative impact on
both the mother and the infant persists despite numerous quantitative studies from multiple
perspectives. Recent studies continue to demonstrate a lack of provider understanding of the
disease of maternal addiction (Benoit et al., 2014). It would seem from this review of the
literature that the voice of pregnant and parenting women with substance use disorders has been
minimally included in prior studies as evidenced by the relatively limited number of qualitative
studies. A more focused review of the literature, highlighting studies of perinatal substance use
disorders that included health care provider-mother-infant relational perspectives within various
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care delivery models, was conducted by this researcher and submitted for publication (Chapter
2). Published studies have yet to identify the relative contribution of multiple risk factors to
adverse outcomes as well as program components most likely to improve outcomes. The
proposed study aims to address that gap by exploring the women’s experiences and perceptions
of care. Nurses and other health care professionals may then be better able to provide efficacious,
holistic care to improve outcomes for these women and their children.
Preliminary Work
Preliminary explorations have provided background information to guide this study.
Telephone conversations and personal meetings with various providers of care for these women
as well as attendance at conferences and meetings where these individuals have spoken have
contributed to a greater awareness of the problem. These care providers identified potential sites
for observation and processes for gaining access to informants in addition to anticipated
challenges. The relationships cultivated with these professionals will enhance this researcher’s
ability to conduct the proposed study. This pre-fieldwork yielded what Hammersley and
Atkinson (2007) termed a foreshadowed problem, the starting point for an investigation that will
evolve as knowledge is gained through inquiry and observation.
Research Design and Methods
Research Design
In the proposed study, ethnographic methods (Hammersley & Atkinson, 2007; Spradley,
1979, 1980) will be used to better understand: (1) the experiences and perceptions of postpartum
women with substance use disorders regarding the care they received during their pregnancy and
through their infants’ hospitalization; and (2) how have their experiences supported or inhibited
their ability to bond with their baby. These methods will include: participant observation of
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postpartum women with substance use disorders at Eastern Maine Medical Center; oral accounts
and formal interviews; and artifact review, such health records and print and electronic resources
provided to the women to support direct care.
Ethnographic studies are designed to understand a culture by learning from the people
within that culture through contextualized examination of their speech, behavior, and artifacts
(Spradley, 1979). A focused ethnography, defined by Munhall (2012) as “the study of small
elements of one society, group, or culture; focus on [a] distinct problem within a specific context
among a small group of people” (p. 291) is particularly suitable for the proposed study. The
topics of inquiry for a focused ethnography are pre-selected, and the short-term yet timeintensive nature of observations are conducive to the study of sensitive topics and complex issues
such as substance use disorders in women during the postpartum period within the limitations
imposed by dissertation studies.
The exploratory nature of ethnographic research requires a focused yet flexible approach
to sampling and data gathering and analysis (Maxwell, 2013). The anticipated population and
study methods described as follows are tentative; the design will emerge as the study progresses.
Setting
This study will be conducted at Eastern Maine Medical Center in Bangor, Maine, which
serves Washington and Penobscot Counties in northern Maine. According to the Maine Office of
Substance Abuse and Mental Health Services (2012) these counties have the highest rates of
opiate addiction in Maine. The 927 drug-affected births reported in Maine in 2013 represent
about 7% of live births (Maine DHHS, 2014). At Eastern Maine Medical Center there were 308
substance-exposed infant reports in 2011, approximately 19% of live births at Eastern Maine
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Medical Center that year; nearly 60% of the mothers of those infants lived in Washington or
Penobscot counties.
Poverty, rural isolation, and Native American culture have been noted to contribute to
poor perinatal outcomes and challenges to access to care (Bohn, 2003; Kent, McClure, Zaitchik,
& Gohlke, 2013). Penobscot and Washington Counties have the highest rates of poverty (Maine
State Planning Office, 2012) and lowest population density in the state (Maine DHHS, 2008).
Nearly 20% of the total population of Washington County is reported to live below the poverty
level; the highest rate of child poverty (nearly 31%) is in Washington County. Maine is one of
the least densely populated states in the country, and both counties include a large number of
unorganized territories (an area having no local, incorporated municipal government). While less
than 1% of the population (0.9% U.S., 0.6% Maine) is identified as Native American, 4.9% of
the population of Washington County is identified as such (Maine CDC, 2103). All of which
underscore the importance of research in this setting.
The majority of pregnant women with substance use disorders in both counties deliver
their babies at Eastern Maine Medical Center (located in Bangor in Penobscot County), the
state’s second largest hospital which serves the northern two-thirds of the state and delivers an
average of 1,600 babies annually. This encompasses a relatively large geographic area, with
towns located in the farthest reaches of Washington and Penobscot Counties situated over 100
miles from the hospital. Three smaller hospitals located 50 to 100 miles from Bangor provide
obstetric services but do not provide care for newborns with neonatal abstinence syndrome
requiring treatment. Newborns delivered at one of those small hospitals, either anticipated or
unplanned, who show signs of neonatal abstinence syndrome in need of treatment are transferred
to Eastern Maine Medical Center. Depending on the circumstances, the mother may or may not
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be transferred with the newborn; typically, the mother has been discharged from the hospital and
must travel to visit the hospitalized newborn.
Access to treatment for substance use disorders is limited, with one outpatient practice in
Washington County and two in Penobscot County, none of which are designed specifically to
address the unique needs of pregnant and parenting women. In contrast, comprehensive
integrated outpatient services for pregnant and parenting women with substance use disorders,
including medical, behavioral, and mental health services, are available in the more densely
populated southern areas of the state.
Women living in Washington County receive a flexible, individualized, strength-based,
integrated, collaborative, wrap-around model of care delivery linking them with various services,
while those in Penobscot County must access those services with limited case management and
without the characteristics of the Washington County model. It has been identified that women
living in remote rural geographic areas with fewer resources who may experience greater
obstacles to accessing services are underrepresented in current studies. The barriers to accessing
adequate resources for substance use disorder recovery, pregnancy, and parenting support,
addressed earlier in this proposal, are clearly present in this setting. Such a setting provides the
opportunity to further explore the factors contributing to unmet needs and potential determinants
of the problem.
Population
The general target population identified for this study will broadly include women living
in Washington and Penobscot Counties identified with a substance use disorder inclusive of
opioid use who deliver their babies at Eastern Maine Medical Center. Clinically important
neonatal withdrawal most commonly results from intrauterine opioid exposure (Hudak & Tan,
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2012), and 56% of substance-exposed infants born at Eastern Maine Medical Center in 2011
were identified as being opiate-exposed. This is a heterogeneous population with respect to
substances used and stage of recovery in addition to the complex array of biopsychosocial,
environmental, and economic variables influencing substance use disorder and recovery (M.
Brown, M. Moran., & M. Withers, personal communication, August 5, 2014).
Sample and Sampling Procedures
The sample will be purposefully selected using maximum variation sampling strategies to
observe a range of informants and activities in a variety of contexts according to demographic,
phenomenal, and theoretical categories (Sandelowski, 1995b). Participants may be of any
race/ethnicity, social class, relationship status, pregnancy status, child custody status, and stage
of recovery. Inclusion criteria for all participants are: (a) have a newborn hospitalized at Eastern
Maine Medical Center, either from birth or through transfer from a smaller facility; (b) have an
identified substance use disorder that includes current use of an opioid (legally prescribed
medication assisted treatment, misuse of prescription opioid medications, or illicit opioids); and
(c) live within Washington or Penobscot County. Participants must be English-speaking and able
to give informed consent.
Sample selection. Sample selection will be dictated by availability and willingness of
participants meeting inclusion criteria as well as establishment of trust with potential informants.
Sampling decisions are dictated by the emergence of data with the intention of including units of
observation (settings, individuals, and activities) representative of pre-selected variables as well
as typical or unusual cases (Sandelowski, 2000).
Sample size. Sample size will be determined as the study evolves; as noted by
Sandelowski (1995b), sample size is a matter of judgment and depends on breadth and depth of
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the data that emerge. Distinction is made between informational redundancy (no new
information is available from newly sampled units) and theoretical saturation (data has been
gathered and analyzed from all theoretical categories) (Coyne, 1997; Sandelowski, 1995b). Data
collected and analyzed concurrently will inform sample configuration and size decisions based
on the richness and variation found in the data. In the proposed study, participants will be
selected that vary as much as possible according to various demographic characteristics based on
literature and personal communication with expert practitioners (Gilligan et al., 2009; Gray,
Edwards, Schultz, & Miranda, 2014; M. Brown, M. Moran., & M. Withers, personal
communication, August 5, 2014): (a) race/ethnicity, (b) social class, (c) relationship status, (d)
pregnancy status, (e) child custody status, (f) stage of recovery, and (g) county of origin (see
Appendix A). This information will be gleaned from the health care record and informant selfdisclosure and recorded by the researcher on a demographic data form. The researcher will aim
for a sample size of 20 to 30 informants to achieve the goal of maximum variation.
Data Collection Procedures
Institutional review board (IRB) approval will be sought from Duquesne University and
Eastern Maine Medical Center; data collection will commence upon these approvals as well as
permission received from physician and nursing leadership at Eastern Maine Medical Center.
Data will be collected primarily through participant observation, oral accounts and formal
interviews, and artifact review. It is anticipated that data will be collected over several months. A
reflective journal will be maintained by the researcher throughout the data collection,
preparation, organization, and analysis process to record memos regarding methodological issues
and decisions and personal impressions as well as to facilitate thinking and stimulate insight
(Maxwell, 2013).
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Participant recruitment. A letter explaining the study and inviting eligible women to
participate will be drafted by the researcher for distribution by providers of care for the women.
Such providers will include but not be limited to prenatal care practices and substance use
services. Included with the letter will be a postcard with a self-addressed, stamped envelope
which a woman can return to the provider if interested in being contacted post-delivery by the
researcher during the mother’s and/or baby’s hospitalization at Eastern Maine Medical Center.
This information will be shared only with the primary team responsible for care of the women
and infants at Eastern Maine Medical Center; the researcher will have no prior knowledge of the
women’s identities. The letter will explain that the researcher will be notified by the perinatal
health care team when she has delivered her baby; only then will the participant be contacted by
the researcher for informed consent, Health Insurance Portability and Accountability Act
(HIPAA) Privacy release, and data collection.
Due to the vulnerability of this population, it is important to maintain the privacy of
potential informants until they have agreed to be contacted. Contacts have been made with
several prominent practice directors (Marjorie Withers, LCPC, Director, Community Caring
Collaborative; Mark Brown, MD, Chief of Pediatrics & Neonatology, Eastern Maine Medical
Center), and through meetings, e-mail, and telephone communication the researcher has
delineated the research purpose and plan to conduct the study with women in their service areas.
They have given support for the study and have arranged contacts with professionals working in
the field who will be instrumental as gatekeepers in identifying potential informants and
facilitating recruitment as previously outlined.
Potential informants will be approached inconspicuously at the hospital as facilitated by
the gatekeepers and permission will be requested to discuss the study. Care will be taken to
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assure privacy during this discussion. Discussions and subsequent interviews will take place in
the woman’s private hospital room or in a private office designated by the gatekeepers,
depending on the woman’s preference and comfort. The presence of family members and friends
will influence the discussion timing and location. The study aim will be explained to the
informant as follows: “I am interested in learning more about how women who have infants and
are also dealing with substance use feel about the care they received during their pregnancy and
since the baby was born. I am also hoping to learn more about how this care has affected mothers
bonding with their babies. I want to learn all this so nurses can take better care of women and
their babies”. The details of data collection and management will be discussed and questions will
be answered, followed by written consent and HIPAA release. Women consenting to participate
in the study will be offered a gift card to a local merchant.
Participant observation. Participant observations occur in social situations identified by
places, people, and activities (Spradley, 1980). As noted by Hammersley and Atkinson (2007),
selection of settings and cases in ethnographic research often occurs on the basis of
foreshadowed problems and pre-fieldwork, and the researcher may not be able to stipulate these
details in advance. Observations will take place in the perinatal units at Eastern Maine Medical
Center facilitated by the providers with whom the researcher communicated during prefieldwork, specifically the neonatologist and social worker who care for the women and their
babies at Eastern Maine Medical Center.
Participation may occur on a spectrum from non-involvement to complete involvement as
an ordinary participant (Spradley, 1980). It is anticipated that participation in the settings
described would be passive to moderately engaged, depending on the comfort and trust of the
participants and the researcher’s familiarity with the activities. The researcher understands that
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practitioners and staff may have concerns about inclusion in these observations. The cultivation
of good field relations includes impression management and addressing concerns of those
working in the field (Hammersley & Atkinson, 2007). A fact sheet about the study will be
drafted by the researcher for distribution to staff and the researcher will be available to answer
questions and concerns (Appendix B1). Family and friends may express similar concerns; a fact
sheet will available for them, as well (Appendix B2).
As noted by several authors, pregnant and parenting women with substance use disorders
have been reported to experience stigma, fear, shame, and guilt, as well as high rates of cooccurring mental health problems, trauma, and post-traumatic stress disorder (Brandon, 2014;
Haug, Duffy, & McCaul, 2014). Therefore, it is important to begin any field observation as
unobtrusively yet transparently as possible to cultivate trust. Informal questions may be asked of
practitioners and staff prior to approaching potential participants to understand and clarify
observed behaviors and practices.
Observations also range from broadly descriptive to more narrowly focused and selective.
Observations may occur over the span of several days while the woman and/or her baby are
hospitalized and will be centered on: (a) participant behavior and demeanor during interviews
and in the hospital environment; (b) interactions between participants and others in the
environment; (c) behavior and demeanor of others in the environment during interactions with
the participants; and (d) the environment and context of care. The purpose of such observations
will be to enhance the researcher’s understanding of informant reports. An observation guide will
be used to focus attention on only the most salient observations (see Appendix C). Observations
will be recorded through handwritten jottings and detailed fieldnotes while in the practice
settings if this can be accomplished discreetly. Descriptions may also be spoken into a digital
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recorder when no participants are present and then transcribed into written fieldnotes for
analysis. Jottings and fieldnotes will be reviewed immediately following each observation and
amended as needed to ensure completeness and accuracy and to facilitate validation of findings
(Maxwell, 2013).
Oral accounts and formal interviews. Spradley (1979) defines speech events as casual
conversations and formal interviews which may serve to validate observations. In this study, the
purpose of oral accounts and formal interviews will be to glean the women’s accounts of their
experiences and perceptions of the care they received during their pregnancy and throughout
their hospitalization as well as what factors of that care may affect their ability to bond with their
infant.
Three main types of interview questions (descriptive, structural, and contrast) will be
used and will be structured as suggested by Spradley (1979). Descriptive grand tour questions
are loosely structured and allow the informants freedom of expression; an example would be:
“Can you tell me about the care you received during your pregnancy?” Grand tour questions may
then lead to mini-tour, example, experience, and native-language questions. Examples include:
“Can you describe the process of making that appointment?”, “Can you give me an example of a
time you felt accepted/judged?”, “What are some of the experiences you’ve had trying to make
appointments?”, and “How would you refer to someone who made you feel that way?” Structural
and contrast questions are more directive and may be used for additional clarification; examples
of such questions may include: “What is the process for scheduling appointments?” and “How
was that experience different from the one you described previously?” An interview guide will
be used to frame the more general research questions; more specific questions will evolve as the
oral accounts and interviews progress (Appendix D).
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Oral accounts and formal interviews will be recorded through handwritten notes and
digital recorder, depending on the comfort of the informant. Interviews will likely vary greatly in
length, depending on informant comfort and any time constraints. Digital recordings will be
transcribed verbatim by an experienced professional transcriptionist as soon as possible after
each interview. Additionally, all recordings, the transcripts, and the fieldnotes will be reviewed
by the principal investigator as soon as is feasible to ensure completeness and accuracy. Process
notes will be written following interviews to record observations such as body language, facial
expressions, and general impressions.
Artifact review. Data in the form of documents and material artifacts may provide
additional information about study settings and serve to either corroborate or challenge
information from observations or informants (Hammersley & Atkinson, 2007). These material
goods may take the form of agency records, informational literature, educational brochures, and
aesthetic features of settings. After consent, pertinent demographic data and relevant health and
social information, such as pregnancy status, self-reported/laboratory confirmed substance use,
and child custody, will be accessed from agency records (Appendix E). Samples of publicly
available information relevant to the study, such as pamphlets and brochures, may be gathered.
Details of aesthetic characteristics of the setting, such as posters, signage, and artwork, may be
recorded through handwritten notes or digital audio or video recording depending on the
propriety to the situation.
Plans for Data Analysis
Analysis of ethnographic data is an evolving and iterative process, occurring
concomitantly with data collection, preparation, and organization to make meaning and search
for patterns (Hammersley & Atkinson, 2007; Spradley, 1979). Fieldnotes and transcriptions will
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be reviewed and proofed against recorded data for accuracy and to serve as preliminary analysis
to guide subsequent data collection (Sandelowski, 1995a). All data will be entered into the
current version of NVivo computer-assisted qualitative data analysis software (CAQDAS) for
organization and assistance with analysis.
Once entered, data will be coded, or categorized, according to the process described by
Maxwell (2013). Coding labels are applied to units or segments of data that appear significant or
relevant in some way and are then explored and compared both within and between cases and
categories. Organizational categorization is the broadest level of ordering the data and may be
established prior to observations and interviews. The participant characteristic matrix (Appendix
A) will facilitate organization of cases for later comparison. As data collection progresses,
constant comparison will be used to create substantive (descriptive) and theoretical (abstract)
categories; annotations and analytic memos will be written to assist with this process and
subsequent comparison within and between cases. Substantive categories reflect the “emic”
view, informant perspectives in their own words taken from recorded data. Theoretical categories
emerge from the researcher’s “etic” interpretation of the data. Data matrices will be developed
from the coding schema to organize and display categories and establish emerging themes.
Validity is related to the accuracy of interpretation of the data and is an important step in
analysis. Creswell (2009) proposed the terms trustworthiness, authenticity, and credibility to
describe validity and suggested a number of validation strategies which are reiterated by
Maxwell (2013). Triangulation involves collection of information from a variety of information
sources to build justification of themes, which are enumerated in the procedures for data
collection. Documentation and analysis of observations, interviews, and artifacts will contain
thick, rich description of data. Feedback, also known as respondent validation or member
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checking, will be solicited from informants to determine accuracy of conclusions. Reflective
journaling will serve to both document analytic decisions and identify possible personal biases.
Although this researcher has some experience with this population, a relatively unfamiliar study
setting has been chosen to promote a more objective stance. A search for negative or discrepant
information adds to the credibility of the findings and will be addressed through discussion of
impressions with dissertation committee members. Additionally, notes, transcripts, and access to
CAQDAS files will be shared with dissertation committee members to facilitate review and
recommendations.
Study Limitations
An ethnographic study of this population may pose certain limitations related to the
reliability and authenticity of information obtained from the informants. The participant pool
may be skewed by gatekeeper bias toward informants deemed more reliable or favored in some
way. Reactivity, or observer effect, may influence how forthright the women might be.
Additionally, the sample size may be restricted due to fluctuations in women meeting inclusion
criteria, their availability and willingness to participate, and attrition. Such limitations will be
addressed by the researcher remaining flexible and opportunistic in observations. Casual
conversations and formal interviews will be augmented with observational and artifact data.
Interviews questions will be varied and structured to encourage honesty while remaining
sensitive to the informants’ vulnerability.
Potential Procedural Problems and Strategies to Address
A number of constraints may be anticipated when conducting fieldwork with a vulnerable
population, particularly within the limitations posed by doctoral dissertation work. Given the
complex challenges of this population, recruitment and retention may be difficult, which is
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closely aligned with development of rapport and establishing trust with both service providers
and prospective informants. Prospective informants will be identified on the advice of those
gatekeepers.
Informants who have consented to participate in the study may experience barriers to
completing the study. The mothers who did not deliver their babies at Eastern Maine Medical
Center or who have already been discharged without their babies may experience logistical
challenges, such as undependable transportation and child care for other children. Women may
also be dealing with challenges such as postpartum discomfort and fatigue, distressing family
and social circumstances, and child protective services involvement. The researcher must be
compassionate and flexible in the scheduling of appointments for formal interviews.
The researcher must be prepared to address disclosure of sensitive information or
potentially illegal activities, particularly if such disclosure suggests child maltreatment. The
informed consent process will include a discussion of mandated reporting. Additionally, the
researcher will collaborate with the hospital social worker to anticipate potential disclosure. In
cases that may not be straightforward, the researcher will consult with her dissertation committee
chair.
Timeline
It is anticipated that once this proposal has been successfully defended and the study is
approved, IRB approval will be sought by November 2014 and the study site secured by
December 2014. Recruitment activities will commence and data collection will begin. Data
collection will continue until data saturation or informational redundancy is recognized. Data
analysis will begin immediately and continue throughout the project. Dissertation defense will
occur once the final analysis has been completed. Final results of the study will be disseminated
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through manuscript submission in a peer-reviewed journal upon successful defense. Due to the
evolving nature of qualitative studies, the exact timeframe for dissertation defense and
dissemination of results cannot be predetermined.
Protection of Research Participants
IRB approval will be obtained from Duquesne University and Eastern Maine Medical
Center, Bangor, Maine. Directors of agencies and practices where potential informants will be
recruited will be approached to obtain permission for letters to be drafted to be given to
prospective informants. The issue of informed consent in qualitative research, particularly
ethnographic studies where interaction with informants may vary over time, has been debated by
a number of researchers (Munhall, 2012). The emergent nature of ethnographic research and the
spectrum of researcher participation from passive observation to active involvement raise the
questions of who must give written informed consent and when that consent is obtained. Munhall
(2012) proposed the concept of process consent whereby permission is renegotiated with each
interaction. Written informed consent will be obtained from informants upon initial contact and
reaffirmed verbally with any subsequent interaction. HIPAA release will also be obtained prior
to review of any agency records. Information sheets explaining the study will be distributed to all
staff involved in the care of the prospective informants. Verbal consent will be obtained from
persons not directly involved in the study but who may become part of the data collection
through their interaction with prospective informants (such as friends and family members).
Potential risks to informants and participants include breach of anonymity and
confidentiality. To minimize these risks, permission will be requested prior to any dialogue, and
conversations and interviews will be conducted privately. All protected health information will
be de-identified and each case will be assigned a number which will be used on all digital files,
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transcripts, fieldnotes, and journal notes. All forms of data will be stored in a locked file cabinet
accessible only to the principal investigator. Electronic files will be preserved on a secure
password protected computer, and electronic transfer of data to the researcher’s dissertation chair
will be accomplished through encrypted files. Digitally recorded data will be retained until
analysis is completed; following completion of dissertation research, data will remain secure at
Duquesne University School of Nursing for five years.
Registered nurses in the state of Maine are mandated to report to the Department of
Health and Human Services any suspicion of child abuse, neglect, or exploitation. This places a
limit on the assurance of confidentiality, which will be outlined in the informed consent process.
The researcher acknowledges that such a justifiable breach of confidentiality may affect
recruitment and retention of participants; however, it is imperative that child welfare take
precedence over potential harm to participants (Fisher, 2009).
Informants may also be at risk for emotional distress by discussing their experiences.
Informants will be reminded that any sharing of information is completely voluntary, that they
can choose to withhold information or withdraw from the study at any time, that admission of
use of illegal substances will not be revealed to anyone, and that any information shared will not
influence their care. Should informants express any distress, referral will be made to the
appropriate service provider.
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Appendix A: Potential participant characteristics
Race/ethnicity

Social
class

Relationship

Pregnancy

Child
Custody

Recovery

Race/ethnicity
Social class
Relationship
Pregnancy
Child custody
Recovery
Location

A. Race/ethnicity
1. White
2. Native American
3. Other
B. Social class
1. Income
2. Education
3. Employment
C. Relationship status (includes all combinations of sexual preferences and partnership
arrangements)
1. Single, never married
2. Single but previously married
3. Married
4. Committed but unmarried
5. Other
D. Pregnancy status (gravidity/parity)
1. Primiparous
2. Multiparous
E. Child custody status (includes family and non-family custody arrangements)
1. Fully retained custody
2. Fully relinquished custody
3. Shared custody
F. Stage of recovery
1. Active recovery (adherent to MAT, no illicit substance use)
2. Relapse (on MAT with continued illicit substance use)
3. Pre-recovery (illicit substance use, no MAT)
G. County of origin
1. Washington
2. Penobscot
3. Other
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Location

Appendix B1
Fact Sheet
(Postpartum and neonatal care - Hospital Personnel)
Duquesne University School of Nursing
Information about a Research Study
________________________________________________________________________
IRB Study #
Consent Form Version Date:
Title of Study: Experiences and Perceptions of Postpartum Women with Substance Use
Disorders Inclusive of Opioids Regarding Their Care
Principal Investigator: Debra Kramlich, MSN, RN, CCRN
Duquesne University Department: School of Nursing
Study Contact Telephone Number: xxx-xxx-xxxx
Study Contact Email: kramlichd@duq.edu
Faculty Advisor: Rebecca Kronk, PhD, MSN, CRNP
Duquesne University Telephone Number: xxx-xxx-xxxx
Email: kronkr@duq.edu
________________________________________________________________
What are some general things you should know about research studies?
You are being asked to take part in a research study. To join the study is voluntary. You may
refuse to join, or you may withdraw your consent to be in the study, for any reason, without
penalty.
Research studies are designed to obtain new knowledge. This new information may help people
in the future. You may not receive any direct benefit from being in the research study. There
also may be risks to being in research studies.
Details about this study are discussed below. It is important that you understand this information
so that you can make an informed choice about being in this research study. You will be given a
copy of this consent form. You should ask the researchers named above, or staff members who
may assist them, any questions you have about this study at any time.
What is the purpose of this study?
The purpose of this research study is to better understand the experiences and perceptions of
postpartum women with substance use disorders inclusive of opioids regarding their care.
How many people will take part in this study?
There will be approximately 20 to 30 women asked to participate in this study. Hospital
personnel may also be observed. These personnel may be asked questions to help the researcher
understand what is going on.
How long will your part in this study last?
You may be observed while engaging in normal activities and routines in the setting. You may
be asked some informal questions to clarify information and help the researcher understand what
is going on. Time spent to answer some questions should be approximately 10-20 minutes.
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What will happen if you take part in the study
I will observe the women in the neonatal care area as they interact with their babies, family
members, other mothers, and hospital staff. The focus of the observations will be on the women.
I will not interfere in the women’s care in any way. I will take notes about the physical setting
and what is happening during care.
I may ask you questions about your work with women who have experienced substance use
disorders and their babies. I may also ask you to clarify activities that were seen or heard during
my observations. This will be done only after the observations are completed. I will take notes
about what you say. You do not have to answer any questions that you do not wish to answer, for
any reason.
What are the possible benefits from being in this study?
Research is designed to benefit society by gaining new knowledge. Your participation is
important to help healthcare providers learn about the experiences and perceptions of postpartum
women with substance use disorders regarding the care they receive. You will not likely benefit
personally from being in this research study.
What are the possible risks or discomforts involved from being in this study?
I do not anticipate you will experience any discomfort or risk from being observed or asked some
informal questions.
How will your privacy be protected?
I will not use your name in any handwritten notes or audio recorded notes. Your name will not
be used when presenting this research to others. You will only be identified in the researcher’s
notes by your profession (e.g., nurse, physician, aide, social worker).
Will you receive anything for being in this study?
You will not receive anything for being in the study.
Will it cost you anything to be in this study?
There are no costs to you for being in the study.
What if you have questions about this study?
You have the right to ask, and have answered, any questions you may have about this research. If
you have questions, or concerns, you should contact me or my academic advisor using the
contact information listed at the beginning of this form.
What if you have questions about your rights as a research participant?
All research on human volunteers is reviewed by a committee that works to protect your rights
and welfare. If you have questions or concerns about your rights as a research subject you may
contact, anonymously if you wish, the Institutional Review Board at __________ or by email to
_____________.

Thank you for helping me with this study.
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Appendix B2
Fact Sheet
(Postpartum and neonatal care - Family)
Duquesne University School of Nursing
Information about a Research Study
________________________________________________________________________
IRB Study #
Consent Form Version Date:
Title of Study: Experiences and Perceptions of Postpartum Women with Substance Use
Disorders Inclusive of Opioids Regarding Their Care
Principal Investigator: Debra Kramlich, MSN, RN, CCRN
Duquesne University Department: School of Nursing
Study Contact Telephone Number: xxx-xxx-xxxx
Study Contact Email: kramlichd@duq.edu
Faculty Advisor: Rebecca Kronk, PhD, MSN, CRNP
Duquesne University Telephone Number: xxx-xxx-xxxx
Email: kronkr@duq.edu
________________________________________________________________
What are some general things you should know about research studies?
You are being asked to take part in a research study. To join the study is voluntary. You may
refuse to join, or you may withdraw your consent to be in the study, for any reason, without
penalty.
Research studies are designed to obtain new knowledge. This new information may help people
in the future. You may not receive any direct benefit from being in the research study. There
also may be risks to being in research studies.
Details about this study are discussed below. It is important that you understand this information
so that you can make an informed choice about being in this research study. You will be given a
copy of this consent form. You should ask the researchers named above, or staff members who
may assist them, any questions you have about this study at any time.
What is the purpose of this study?
The purpose of this research study is to better understand the experiences and perceptions of
postpartum women with substance use disorders inclusive of opioids regarding their care.
How many people will take part in this study?
There will be approximately 20 to 30 women asked to participate in this study. Hospital
personnel and family members may also be observed in the hospital setting.

81

How long will your part in this study last?
You may be observed while in the hospital setting (most likely your family member’s hospital
room or in the common family area). You will only be observed when with your family member.
What will happen if you take part in the study
I will observe the women in the neonatal care area as they interact with their babies, family
members, other mothers, and hospital staff. The focus of the observations will be on the women.
I will not interfere in the women’s care in any way. I will take notes about the physical setting
and what is happening during care.
What are the possible benefits from being in this study?
Research is designed to benefit society by gaining new knowledge. Your participation is
important to help healthcare providers learn about the experiences and perceptions of postpartum
women with substance use disorders regarding the care they receive. You will not likely benefit
personally from being in this research study.
What are the possible risks or discomforts involved from being in this study?
I do not anticipate you will experience any discomfort or risk from being observed.
How will your privacy be protected?
I will not use your name in any handwritten notes or audio recorded notes. Your name will not
be used when presenting this research to others. You will only be identified in the researcher’s
notes by your relationship to the patient (e.g., husband, sister, friend).
Will you receive anything for being in this study?
You will not receive anything for being in the study.
Will it cost you anything to be in this study?
There are no costs to you for being in the study.
What if you have questions about this study?
You have the right to ask, and have answered, any questions you may have about this research. If
you have questions, or concerns, you should contact me or my academic advisor using the
contact information listed at the beginning of this form.
What if you have questions about your rights as a research participant?
All research on human volunteers is reviewed by a committee that works to protect your rights
and welfare. If you have questions or concerns about your rights as a research subject you may
contact, anonymously if you wish, the Institutional Review Board at __________ or by email to
_____________.

Thank you for helping me with this study.
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Appendix C: Observation guide (adapted from Spradley, 1980)
Focus areas for observations:
1. Participant behavior/demeanor during interviews
2. Participant behavior/demeanor in the hospital environment
3. Participant interactions with staff
4. Participant interactions with newborn
5. Participant interactions with friends/family members
6. Participant interactions with other patients (if appropriate – as an example, if
several consenting participants happen to be interacting in common areas on the
unit, this interaction would be observed)
7. Staff interactions specifically involving consenting participants (as an example,
change of shift report, interdisciplinary report)
8. Behavior/demeanor of others in the environment during interactions with
participants
9. Contextual/environmental factors impacting behavior and interaction
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Appendix D: Interview guide (adapted from Spradley, 1979)
Interviews will start with broad, open-ended grand tour questions; subsequent questions will be
based on the answers to the grand tour questions.
Topic areas to be covered:
1. Care received during pregnancy
a. Experiences of making appointments
b. Experiences of getting to appointments
c. Interactions with care providers
2. Hospital experiences
a. Experiences of being in the hospital
b. Experiences of getting to the hospital (if mother discharged and baby still
there)
c. Interactions with care providers
d. Preparation for discharge
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Appendix E
Medical Record Data Extraction Guide
Demographics:
Age ________
Race/ethnicity _________________
County of origin _______________________
Education ____________________
Employment status ________________________
Income level (may be deduced from public assistance status) ________________
Marital status ____________________
Others in Household
None ______
Partner _______
Children _______
Others ________
Child custody status ______________________
Medical Information:
Pregnancy status ___________________
Substance(s) used __________
Stage of substance use recovery ________________
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Challenges and Facilitators of Recruitment: Lessons Learned from Conducting a
Focused Ethnography in a Vulnerable Rural Population
Debra Kramlich, Rebecca Kronk, and Karen Jakub
Duquesne University
Abstract
The purpose of this article is to describe the challenges and facilitators of
recruitment encountered in an ethnographic dissertation study of rural women with
substance use disorders during the perinatal period. While the study is being
conducted in the hospital setting post-delivery, potential participants who meet
inclusion criteria are identified by practitioners through a number of perinatal
practices within a wide geographic area as well as by inpatient social workers.
Recruitment in this vulnerable and often socially disadvantaged population has
been found to be challenging with regard to ethical approval, participant eligibility
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and availability, practice changes, and discrepancies in the recruitment process. The
authors discuss these challenges and describe the process of practitioner
engagement to facilitate participant recruitment and lessons learned in the process.
Keywords: Ethnography, Vulnerable Population, Socially Disadvantaged,
Recruitment Challenges

Background
The first author (herein referred to in the first person) lives in a rural area in the
northeastern United States identified as having one of the highest rates of prescription opiate
drug misuse and neonatal abstinence syndrome (NAS) in the country (Hayes & Brown, 2012; Ko
et al., 2016). As a registered nurse caring for newborns with NAS, I was concerned with this
trend and sought to better understand the determinants of the issue. This interest led to a search
of the evidence and subsequent focus of the current dissertation study. The second and third
authors serve as my advisor/dissertation committee chair and methods expert, respectively,
providing continuous consultation throughout the process.
Women with substance use disorders continue to face numerous impediments to
accessing available resources for recovery and parenting support (Fraser, Barnes, Biggs, & Kain,
2007). Substance use disorder in women is associated with increased prevalence of mental
illness, histories of physical and sexual abuse, and medical and social problems (Milligan et al.,
2010). Pregnant and parenting women with substance use disorders have been reported to
experience stigma, fear, shame, and guilt, as well as high rates of co-occurring mental health
problems, trauma, and post-traumatic stress disorder (Brandon, 2014; Haug, Duffy, & McCaul,
2014). Studies have shown that rural healthcare disparities, specifically those related to poverty,
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further complicate access to treatment, and societal stigma and lack of resources further
contribute to the negative outcomes for both mother and child (Lander et al., 2013). This is
particularly concerning in light of findings that protective factors, such as caretaker involvement
and family resources, may moderate the negative effects of substance use on the developing
child (Bada et al., 2012).
Of newborns prenatally exposed to addictive substances, 50% to 90% will experience
some degree of neonatal abstinence syndrome (NAS), a term applied to a constellation of
symptoms characterized by dysregulation and hyperirritability of the central and autonomic
nervous, respiratory, and gastrointestinal systems (Sublett, 2013). Symptoms are treated with a
combination of pharmacologic and non-pharmacologic therapies typically requiring specialized
neonatal care with an overall mean length of hospital stay of 16 days, increasing to 23 days for
newborns requiring pharmacologic treatment (Patrick, Davis, Lehman, & Cooper, 2015). Despite
increasing attention on this problem and evidence-based recommendations (Dow et al., 2012;
Goettler & Tschudin, 2014; Hudak & Tan, 2012; Jansson, Velez, & Harrow, 2009; Lucas &
Knobel, 2012; Queensland & Neonatal Clinical Guidelines, 2010; Winklbaur et al., 2008),
management remains inconsistent, hospital length of stay has not declined, and expenditures
continue to rise (Patrick et al., 2015).
Perinatal substance use directly impacts two constituencies, the woman and her offspring,
and therefore the problem has been examined from a variety of perspectives. Numerous
quantitative studies have been conducted to identify factors regarding maternal drug use which
may be predictive of neonatal outcomes, such as the type and amount of medication-assisted
treatment for opioid use. Several retrospective studies associated higher doses of maternal
methadone dose with higher incidence of neonatal abstinence syndrome as well as duration of
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neonatal abstinence syndrome treatment (Dryden, Young, Hepburn, & Mactier, 2009; Lim,
Prasad, Samuels, Gardner, & Cordero, 2009). These findings contradicted those of other studies,
which reported no such correlation (Pizarro et al., 2011; Seligman et al., 2008). One prospective
cohort study also concluded that the incidence and duration of neonatal abstinence syndrome was
not affected by methadone dose (Cleary et al., 2012). McCarthy, Leamon, Stenson, and Biles
(2008) noted that infants of women who began methadone treatment prior to conception had
better outcomes compared with those whose mothers began treatment mid-pregnancy.
Similar conflicting results have been noted in studies comparing maternal methadone and
buprenorphine medication-assisted treatment. Several studies suggested improved neonatal
outcomes, such as lower incidence and severity of neonatal abstinence syndrome, in infants
exposed to buprenorphine as compared with methadone exposure (Binder & Vavrinkova, 2008;
Coyle et al., 2012; Gaalema et al., 2012; Kakko, Heilig, & Sarman, 2008; Salisbury et al., 2012).
Other studies found no such differences (Jones et al., 2010; Welle-Strand et al., 2013). Patel and
colleagues (2013) noted no difference in neonatal abstinence syndrome expression when
comparing infants exposed to buprenorphine to those exposed to illicit opiates. The concomitant
use of illicit substance, as well as alcohol and tobacco, with medication-assisted treatment seems
to confound the results of these studies (Blandthorn, Forster, & Love, 2011; Kaltenbach et al.,
2012).
Many of the aforementioned studies have been retrospective reviews of clinical data or
secondary analyses of data from larger studies. Findings of several prospective studies regarding
severity of neonatal abstinence syndrome relative to type and dose of maternal substance or
medication-assisted treatment have been equally conflicting. Winklbaur-Hausknost and
colleagues (2013) found that maternal treatment resulting in reduced illicit drug use throughout
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pregnancy had no influence on neonatal outcomes in two separate studies. In a systematic review
and meta-analysis, Cleary and colleagues (2010) found no clear link between neonatal abstinence
syndrome severity and methadone dose. Similarly, Thajam, Atkinson, Sibley, and Lavender
(2010) found no correlation between amount and type of fetal opioid exposure and neonatal
abstinence syndrome expression in eight of the 10 studies they reviewed. In a systematic review
of the literature, Milligan and colleagues (2010) noted that quantitative and interventional studies
have yet to produce sustained, efficacious improvement in outcomes for these mothers and
children. It may be concluded that a singular focus on drug type and dose fails to account for the
complex array of factors contributing to neonatal outcomes.
Literature regarding care of the newborn with neonatal abstinence syndrome has been
equally inconclusive (Dryden, Young, Hepburn, & Mactier, 2009; Sublett, 2013; Velez, Jansson,
Schroeder, & Williams, 2009). It appears that factors other than maternal medication-assisted
treatment, such as maternal-infant bonding, have greater influence on neonatal outcomes:


Care of neonatal abstinence syndrome infants on the postpartum unit with their
mothers, rather than in the NICU, resulted in shorter duration of treatment and
hospital stay (Saiki, Lee, Hannam, & Greenough, 2010).



Infants discharged home on a methadone weaning protocol with support from a
multidisciplinary team, as opposed to a traditional inpatient methadone wean,
resulted in shorter hospital stays and reduced cost (Backes et al., 2012; Smirk,
Bowman, Doyle, & Kamlin, 2014) .



Substantial breast milk intake significantly reduced severity of neonatal
abstinence syndrome symptoms, delayed the onset of symptoms, and decreased
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the need for pharmacologic treatment (Abdel-Latif et al., 2006; Dryden et al.,
2009).
Early and adequate prenatal care has been shown to mitigate the negative effects of
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning,
2012). Studies of early identification, engagement, and treatment retention of pregnant women
using integrated substance abuse and perinatal services are showing potential benefits in the
promotion of maternal-infant bonding (Burns, Mattick, Lim, & Wallace, 2007; Mayet,
Groshkova, Morgan, MacCormack, & Strang, 2008; Meyer et al., 2012; Racine, Motz, Leslie, &
Pepler, 2009; Suchman, Pajulo, DeCoste, & Mayes, 2006; Taylor et al., 2012). In a recently
published systematic review, Jumah (2016) identified location as a major factor in accessibility
to treatment for rural, opioid-dependent pregnant women, yet she also noted that gender issues
and stigma remain largely unaddressed in the literature. Studies of harm-reduction approaches in
Britain, the Netherlands, and Canada have shown positive outcomes in terms of lower rates of
child protective involvement and withdrawal symptoms in infants (Boyd & Marcellus, 2007).
Pilot studies in the U.S. have shown similar results (Wright et al., 2012). The programs described
in the literature have used a variety of interventions, including integrated prenatal and substance
abuse services and motivational incentives, so it is unclear which aspects of a harm-reduction
approach contribute to outcomes. A focused review of the literature, highlighting studies of
perinatal substance use disorders that included health care provider-mother-infant relational
perspectives within various care delivery models, concluded that published studies have yet to
identify the relative contribution of multiple risk factors to adverse outcomes as well as program
components most likely to improve outcomes (Kramlich & Kronk, 2015).
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It would seem from this review of the literature that the voice of pregnant and parenting
women with substance use disorders has been minimally included in prior studies as evidenced
by the relatively limited number of qualitative studies. Woodley and Lockard (2016) noted that
qualitative research methods may provide more opportunities to engage with marginalized
groups through personal connections as compared to quantitative methods, therefore informing
my choice of study design. My dissertation study aims to address the gaps in the literature by
exploring the women’s experiences and perceptions of care, leading me to ask several questions:
a) What are the experiences and perceptions of women with substance use disorder regarding the
care they received during their pregnancy and through their infants’ hospitalization? and b) How
have their experiences supported or inhibited their ability to bond with their baby? For research
purposes, pregnant women, human fetuses, and neonates are identified as vulnerable populations
and are afforded additional protection (Protection of Human Research Subjects, 2001).
Additionally, Flaskerud and Winslow (1998) suggest that persons who are poor, subjected to
discrimination, intolerance, subordination, stigma, politically marginalized, disenfranchised, and
denied human rights may be considered vulnerable. Studies have shown that women with
substance use disorder, particularly those who are poor, indigenous, and members of racial
minorities, “are the most vulnerable to arrest, child apprehension, and poor health outcomes”
(Boyd & Marcellus, 2007, p. 14). Access to and engagement of participants from vulnerable,
socially disadvantaged populations have been found to be challenging due to mistrust of
research/researchers and fear of authority, public exposure, and potential harm, stigma,
mistreatment, or exploitation (Bonevski et al., 2014). For the reasons noted above, pregnant and
parenting women with substance use disorder may be reluctant to participate in research studies
due to the perceived and real risk of prosecution and incarceration, particularly in light of the
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criminalization of drug use during pregnancy in several states (Miranda, Dixon, & Reyes, 2015).
Gatekeepers may serve as both barriers to and facilitators of participant recruitment; the
relationship between vulnerable individuals and the health professionals caring for them may
potentially inhibit the recruitment process (Bonevski et al., 2014; Namageyo-Funa et al., 2014).
Study Purpose and Design
Women living in remote rural geographic areas with fewer resources who may
experience greater obstacles to accessing services have been underrepresented in prior studies.
An exploration of the experiences of women with substance use disorder regarding the care they
received for pregnancy, parenting, recovery, and psychosocial and economic issues is being
undertaken to identify unmet needs. It is hoped that results of the study may contribute to a better
understanding of the determinants of the problems associated with perinatal substance use to
inform development of efficacious models of care. These findings may be of particular interest to
the health care and psychosocial support services professionals who care for these women, as
well as policymakers tasked with addressing issues related to substance use disorders.
Ethnographic studies are designed to understand a culture by learning from the people
within that culture through contextualized examination of their speech, behavior, and artifacts
(Spradley, 1979). Focused ethnography, defined by Munhall (2012) as “the study of small
elements of one society, group, or culture; focus on [a] distinct problem within a specific context
among a small group of people” (p. 291), may be particularly suitable for the study of
vulnerable, stigmatized groups and sensitive issues (Li, 2008; Stahler & Cohen, 2000). The
topics of inquiry for a focused ethnography are pre-selected, and the short-term yet timeintensive nature of observations are conducive to the study of sensitive topics and complex issues
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such as substance use disorders in women during the perinatal period within the limitations
imposed by dissertation studies.
This study is being conducted at a large tertiary care hospital serving the northern twothirds of a state in the northeastern United States. This encompasses a relatively large geographic
range, with towns located in the farthest reaches of the service region situated well over 100
miles from the hospital. The area is also identified as having the lowest population density and
highest rates of poverty in the state, one of the highest rates of opiate addiction in the country,
and a Native American population greater than five times the national average. These variables
have previously been noted to be barriers to access to adequate resources for substance use
disorder recovery, pregnancy, and parenting support. The majority of pregnant women with
substance use disorders in the area deliver their babies at this hospital. Three smaller hospitals
located 50 to 100 miles from the hospital provide obstetric services but do not provide care for
unstable substance-exposed newborns; newborns delivered at one of those small hospitals, either
anticipated or unplanned, who show signs of neonatal abstinence syndrome in need of escalating
medication-assisted treatment are transferred. Depending on the circumstances, the mother may
or may not be transferred with the newborn; typically, the mother has been discharged from the
hospital and must travel to visit the hospitalized newborn.
I engaged in preliminary exploration which provided background information to guide
this study. Telephone conversations and personal meetings with various providers of care for
these women as well as attendance at conferences and meetings where these individuals have
spoken contributed to a greater awareness of the problem. These care providers identified
potential sites for observation and processes for gaining access to informants in addition to
anticipated challenges. The relationships cultivated with these professionals has enhanced my
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ability to conduct the proposed study. This pre-fieldwork yielded what Hammersley and
Atkinson (2007) termed a foreshadowed problem, the starting point for an investigation that will
evolve as knowledge is gained through inquiry and observation.
This study is currently in progress; to date, primarily due to the recruitment challenges,
only 13 participants have consented to interviews, observations, and data collection. The original
prenatal recruitment method, as outlined below, yielded less than half of these participants; the
remainder have been recruited postpartum through the hospital social worker subsequent to
protocol amendment. Data in the form of transcribed interviews, participant observation, field
notes, demographic data, and artifact reviews has undergone preliminary analysis and initial
coding. Deeper analysis is currently underway and will involve constant comparison to create
substantive (descriptive) and theoretical (abstract) categories. Data matrices will be developed
from the coding schema to organize and display categories and establish emerging themes.
Recruitment Challenges
Multiple Processes for Ethical Approval
To conduct this study, ethical approval from several Institutional Review Boards
(IRBs) was required, a process that took nearly eight months. IRB members, particularly at the
study hospital, were concerned about maintaining privacy of the women during prenatal
recruitment since special protection is required for research involving pregnant women, fetuses,
and neonates (Protection of Human Research Subjects, 2001). After multiple protocol revisions
and two full hospital IRB reviews, it was agreed that a researcher-designed informational flyer
would be made available to eligible women in the perinatal practices. Women interested in the
study would give permission for me to be contacted by the hospital social worker after delivery
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to initiate informed consent, Health Insurance Portability and Accountability Act (HIPAA)
Privacy release, and subsequent data collection.
The ethical approval process itself required a certain degree of gatekeeping, consistent
with the findings of Walker and Reed (2011). The university IRB requested letters of agreement
from the four perinatal practices to allow and participate in recruitment; the hospital also needed
to provide a letter of agreement for the study to be conducted, separate from their own IRB
approval process. For a variety of reasons, it took over three months to receive the letters.
As noted by Walker and Reed (2011), gatekeepers of ethical approval for research in
vulnerable populations and sensitive subjects can serve as facilitators and barriers for the
protection of their organizations and participants. Reviewers of the original study protocol
requested that researcher-developed fact sheets for gaining verbal consent by hospital personnel
and participants’ family and friends for observation during data collection be eliminated,
deeming them confusing and unnecessary. The hospital’s IRB, however, expressed concern with
the absence of a verbal consent process for non-participant observations, so the fact sheets were
reinstated. Additionally, the method of distribution of the research information flyer at the
perinatal practices evolved with each IRB review. The first reviewers were uneasy with the idea
that eligible participants would be identified and given a flyer by practitioners due to negative
experiences reported during previous full IRB protocol reviews, the details of which were not
disclosed. They suggested instead that recruitment materials with researcher contact information
be placed in waiting areas and examination rooms. The hospital IRB, on the other hand, disliked
that procedure and asked that practitioners hand-deliver to eligible women the recruitment flyer
with a pre-addressed stamped envelope for return to me. The recruitment process, therefore,
came full circle.
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The extended process for ethical approval as well as the time lapse between perinatal
practice site commitment, subsequent initiation of recruitment, and postpartum data collection
appear to have negatively impacted recruitment. As will be noted, practitioners seemed to forget
recruitment procedures, eligibility criteria, or the study itself, or lose the recruitment materials.
Additionally, the reliance on busy practitioners to facilitate recruitment due to privacy concerns,
rather than direct recruitment by the researcher, may also reduce the potential participant pool.
Lack of time and gatekeeper bias toward participants deemed more reliable or favored in some
way may also skew the participant pool. My experience is consistent with challenges noted by
Bonevski et al. (2014) and Namageyo-Funa et al. (2014).
Ineligibility
One inclusion criterion for the study is a personal substance use history inclusive of
opioids, whether that be past or current use of illicit substances, misuse of prescription opioids,
or engagement in opioid-replacement therapy, in recovery or relapsing. Several of the women
who returned flyers early in the process did not in fact have a personal substance use history.
They indicated that they misread or misunderstood the criteria for inclusion in the study and
thought having a friend or relative with a substance use history would qualify them.
Women to be considered for the study also need to be currently pregnant since informed
consent and data collection commences once the woman delivers her baby. Several women
returning flyers, when asked about their expected due dates, responded that they had delivered a
number of months prior. This discovery illuminated a limitation of the study which did not allow
access to women once they and their baby were discharged from the hospital.
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Unavailability
Given the demographic profile of the women most likely eligible for the study (rural,
higher rates of poverty, relapsing nature of substance use disorder), it was not surprising that I
was never able to reach three of the women who returned flyers despite multiple attempts. This is
not an unusual phenomenon (van Wijk, 2014). Wireless coverage in the northern part of the state
is often unreliable. Residents turn to web-based service and prepaid phones for numerous
reasons. Economic instability may cause unpaid bills and disconnected service. Lapses in
judgment and avoidance of law enforcement also may result in full voice mailboxes and
unreturned calls. In one case, the message on every attempt was “number unreachable.” Multiple
voice messages left over a period of weeks, with the other two potential participants, were never
returned.
Practice Change
When the study was initially proposed, all babies born with any addictive substance
exposure in the northern part of the state were automatically transferred to the large hospital
where the study was approved. In the time between study proposal, IRB approval, and
commencement of recruitment, practices at the smaller hospitals evolved. Substance-exposed
babies not requiring pharmacologic treatment were being retained for observation at the small
hospitals. One of the earliest flyers I received was returned by a woman whose first baby
required transfer for observation and treatment; she was hopeful that this delivery would be
different. Indeed, as it turned out, she and her baby were able to stay in their local community
hospital, which was a positive outcome for them but the loss of a study participant.
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Observed Anomalies
The recruitment flyers were color-coded by perinatal practice site to facilitate data
collection and organization. I supplied what should have been sufficient numbers of flyers and
pre-addressed stamped envelopes to each practice with the promise of more as needed. I
maintained close contact with each practice to check on the status of the supply of flyers. Several
months into recruitment, white flyers in envelopes not provided by me began to appear, some
with stamps that had not been cancelled and appeared to have been left in my mailbox without
going through the postal service. This was a bit unsettling, as I live well over 100 miles from the
hospital and nearest perinatal practices. Coincidentally, all but one of those irregular returns were
also from women with whom I could not connect. I again contacted the practitioners to reinforce
the recruitment process, and the anomalies ceased.
Questionable Leadership Approval
After months of recruitment, I noticed that one of the recruitment sites had not yet
yielded a returned flyer. This might not be unusual given that it is a small rural perinatal practice;
however, the rate of perinatal substance use disorder in that county is among the highest in the
state. Additionally, the senior administrator who had granted permission for recruitment was no
longer at the hospital and the remaining administrators were unaware of the study, a finding that
was revealed when I sought an amendment to the original study proposal. Unfortunately, this
experience seemed to create enough uncertainty that the new senior administration elected to
prohibit further recruitment efforts.
Recruitment Facilitators
I initially contacted perinatal practice leadership to delineate the research purpose and
plan to conduct the study with women in their service area. Hammersley and Atkinson (2007)
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identify individuals with control over access to key informants or potential participants as
gatekeepers and suggest that “identifying the relevant gatekeepers is not always straightforward”
(p. 49). It has been noted that most health-related research studies of human participants involve
collaboration with other health care professionals, and cultivating relationships with key
administrative, clinical, and support staff is crucial to successful recruitment at the practice sites
(Patel, Doku, & Tennakoon, 2003; van Wijk, 2014). I connected with the practice leaders
through the process of community networking as described during preliminary work; often the
support staff facilitated introductions with practice leaders. Leadership positions ranged from
practice manager to hospital senior administration to health care practitioner. I then arranged
initial meetings with the practitioners designated to identify potential informants and facilitate
recruitment. I have attempted to maintain ongoing dialogue with these practices through personal
meetings, e-mail, and telephone communication to further cultivate the relationships. This
relationship-building has proven to be beneficial to the recruitment and data collection process.
I was aware of the potential constraints and limitations posed by study of a vulnerable
rural population, including distance, time constraints, fluctuations in women meeting inclusion
criteria, their availability and willingness to participate, and attrition. The relationships fostered
with perinatal practitioners have mitigated the challenges, but my willingness to remain flexible,
sensitive, and responsive to practitioner and participant needs has been equally important.
Conclusions and Lessons Learned
Conversations about the recruitment challenges with my advisor and the hospital social
workers led to possible strategies to improve the recruitment process. The hospital social workers
suspected many eligible participants were not being identified through the perinatal practices due
to practitioner time constraints and confusion regarding the process, which is consistent with
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other reports in the literature (Namageyo-Funa et al., 2014). They suggested direct recruitment in
the hospital and were willing to act as facilitators since they were already familiar with the study
and the population. Subsequently, amendments to the original study proposal were approved by
the IRB, and two participants have been recruited into the study.
Qualitative research takes time which can result in changes in practice patterns
(Hammersley & Atkinson, 2007) and which was certainly the case in the present study. The
revelation that the small rural hospitals were changing practice and beginning to retain
substance-exposed newborns for observation unless pharmacologic treatment was needed
motivated me to seek an additional protocol amendment to allow direct recruitment and data
collection at those rural hospitals. The IRB has approved the amendment and I have met with
senior hospital leadership and the perinatal unit nursing staff to initiate the process. A parallel
process was advancing slowly through the other rural hospital where a complete senior
leadership turnover has occurred and the original administrative approval was in question. I have
spent countless hours meeting in person and by conference calls with the current administration
to establish legitimacy and regain trust so the study may advance, to no avail.
A prior study by Namageyo-Funa et al. (2014) identified recruitment challenges,
including access to participants with the use of one recruitment strategy and limited interview
locations. These issues have become evident in the current study. The distribution of flyers
through gatekeepers at multiple sites, with diverse practices and processes, and the restriction of
data collection to the inpatient postpartum setting, seem to have undermined recruitment rather
than enhanced it. I anticipate that expansion of the study to the small rural hospitals may mitigate
some of those constraints. I did contact a number of substance use disorder treatment practices in
the service area on the advice of the social workers; they hypothesized that, although pregnant
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women may receive integrated services for pregnancy and substance use, some women may slip
through the cracks and be more easily recruited through a substance abuse program. Those
practitioners politely declined to participate, indicating that they did not feel they could add to
the current recruitment efforts. In consideration of the potential participants excluded due to lack
of personal substance use history but who had friends or relatives with substance use disorders, I
am now offering additional flyers and envelopes to study participants to share with contacts who
may be interested. As indicated by several potential participants who were excluded due to
remote delivery and hospital discharge dates, the ability to collect data in the postpartum period
following hospital discharge may have further augmented informant recruitment. Although this
strategy was considered in the original study proposal development, it was rejected for
consideration of my safety. In hindsight, I would have contemplated other creative solutions,
such as data collection at the same perinatal practices in the postpartum period rather than at
private homes or other public places.
As noted by Maxwell (2013), the exploratory nature of ethnographic research requires a
focused yet flexible approach to sampling and data gathering, which extends to participant
recruitment and negotiating of relationships. Maxwell further asserts that “research
relationships…can facilitate or hinder other aspects of the research design” (p. 91), and
gatekeepers are included in the established relationships. Despite careful forethought and
planning, I encountered numerous challenges in the recruitment process alone. It is hoped that
through this reflection and reconsideration of methodological decisions, other qualitative
researchers might avoid and be prepared for similar challenges. Persistence in overcoming
barriers to inclusion of already marginalized and underrepresented populations in research
studies may significantly impact their outcomes.
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CHAPTERS 5 AND 6
Chapters 5 and 6 comprise the final study findings and discussion in manuscript form for
submission for publication to Qualitative Health Research.

Experiences and Perceptions of Rural Postpartum Women with Substance Use Disorders
Inclusive of Opioids Regarding Their Care
Debra Kramlich
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Abstract
Perinatal opioid use and neonatal withdrawal continue to rise rapidly in the face of the
growing epidemic of opioid addiction in the United States, with rural areas more severely
impacted. Despite several decades of research and development of practice guidelines, maternal
and neonatal outcomes have not improved substantially. Through the voices of 13 rural women,
this focused ethnography sought to better understand the experience of accessing treatment and
care necessary for substance use disorder recovery, pregnancy, and parenting. Their personal
accounts, reinforced by participant observation and artifact review, uncovered three domains
with underlying themes: challenges of getting treatment and care (service availability,
distance/geographic location, transportation, provider collaboration/coordination, physical and
emotional safety), opportunities to bond (proximity, information), and relationships (respect,
empathy, familiarity, inclusion, interactions with care providers). The findings highlight the need
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for providers and policy makers to reduce barriers to treatment and care related to logistics,
stigma, judgment, and lack of understanding of perinatal addiction.
Background
The United States is facing an escalating epidemic of opioid addiction. Since 1999, sales
of prescription opioid analgesics and the rate of unintentional opioid-related overdose deaths
have more than quadrupled, with women being affected more than men, disrupting the health,
social, and economic welfare of the country (American Society of Addiction Medicine [ASAM],
2016; Senate Caucus, 2014; United States Department of Health and Human Services [HHS],
2016). Additionally, emergency room visits for nonmedical prescription opioid use increased by
183% from 2004 to 2011, and there was a 900% increase in individuals seeking treatment for
prescription opioid addiction from 1997 to 2011 (Kolodny et al., 2015; Substance Abuse and
Mental Health Services Administration [SAMHSA], 2013). The opioid epidemic has been
accompanied by a sharp rise in perinatal exposure to opioids and subsequent increase in the
incidence of neonatal abstinence syndrome from 1.5 to 6.0 cases per 1000 hospital births from
1999 to 2013 (Ko et al., 2016; Patrick et al., 2015; Pryor et al., 2017; Tolia et al., 2015). Data
show disproportionately higher rates of perinatal substance use in rural areas, with three states
(Maine, Vermont, and West Virginia) experiencing greater than tenfold increases and NAS
incidence rates > 30 per 1,000 hospital births (Ko et al., 2016; Villapiano, Winkelman,
Kozhimannil, Davis, & Patrick, 2016).
Neonatal abstinence syndrome (NAS) is a term used to describe the postnatal opioid
withdrawal that may occur in up to 94% of newborns prenatally exposed to prescription or illicit
opioids used by a woman during pregnancy (McQueen & Murphy-Oikonen, 2016). This statistic
has been questioned due to the variability in identification of NAS as well as the influence of
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factors such as polysubstance exposure, timing and level of exposure, and social determinants of
maternal health (Clark & Rohan, 2015; Tolia et al., 2015). Clinical manifestation of NAS are
related to dysregulation and hyperirritability of the central and autonomic nervous, respiratory,
and gastrointestinal systems and can range from mild tremors and irritability to excessive weight
loss and seizures (McQueen & Murphy-Oikonen, 2016; Sublett, 2013). Symptoms, which
generally appear within the first five days of life, are treated with a combination of
pharmacologic and non-pharmacologic therapies (swaddling, rocking, dark quiet room, pacifier)
which have historically required specialized care in the neonatal intensive care unit (NICU). In
one large national data set, the median length of hospital stay for NAS was reported to be 19
days (Tolia et al., 2015). Studies have suggested that excessive prenatal substance exposure may
result in negative birth outcomes, including low birthweight and prematurity (Walton-Moss,
McIntosh, Conrad, & Kiefer, 2009), delayed cognitive and motor development (Mactier, 2013),
and increased child protective involvement (Lean, Pritchard, & Woodward, 2013), placing an
even greater burden on health care, social welfare, and foster care services. In short, perinatal
opioid use is a significant and costly public health issue (Patrick et al., 2012).
Perinatal substance use directly impacts both the woman and her developing child, and
attempts to identify variables that may be predictive of neonatal outcomes have produced
conflicting results. Studies have failed to demonstrate a predictable correlation between duration,
timing, and total cumulative dose of prescription opioids on incidence or severity of NAS (Desai
et al., 2015; Kraft, Stover, & Davis, 2016; Stover & Davis, 2015). A singular focus on drug type
and dose seems unable to account for the complex array of factors contributing to neonatal
outcomes. Additionally, no definitive evidence exists that opioid exposure alone results in
negative long-term developmental outcomes in children; adverse childhood experiences and
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toxic stress, which includes health disparities related to poverty and rurality, contribute to poor
outcomes and may be mitigated by access to treatment and care (Holbrook & Nguyen, 2015;
Shonkoff & Garner, 2012; Sword et al., 2009).
Studies focusing on care of the newborn with neonatal abstinence syndrome have been
equally inconclusive. This is likely due, in part, to wide variations in care of opioid-exposed
newborns and lack of standardized NAS treatment (Bogen, Whalen, Kair, Vining, & King, 2016;
Kelly et al., 2016). Factors other than maternal medication-assisted treatment, such as maternalinfant bonding, seem to influence neonatal outcomes. Maternal-infant bonding has been
described as an affective process with behavioral and biological indicators (Altaweli & Roberts,
2010; Bicking Kinsey & Hupcey, 2013). Breastfeeding and rooming-in during the immediate
postpartum period has been found to promote bonding (Altaweli & Roberts, 2010), while
physical or emotional separation of the mother from the newborn can inhibit bonding (Bicking
Kinsey & Hupcey, 2013). Increased parental presence at the newborn’s bedside has been shown
to increase rates of breastfeeding, reduce need for pharmacologic treatment, shorten duration of
treatment, and decrease length of hospital stay (Cirillo & Francis, 2016; Hodgson & Abrahams,
2012; Hünseler, Brückle, Roth, & Kribs, 2013; Newman et al., 2015).
Early and adequate prenatal care has been shown to alleviate negative effects of
substance use disorders during pregnancy (Wright, Schuetter, Fombonne, Stephenson, & Haning,
2012). Reduction of physical and psychological barriers to women’s access to adequate care is
necessary to promote engagement (Lefebvre et al., 2010; Saia et al., 2016). Studies of early
identification, engagement, and treatment retention of pregnant women using integrated
substance abuse and perinatal services are demonstrating potential benefits in the promotion of
maternal-infant bonding (Meyer et al., 2012; Taylor et al., 2012). Harm reduction approaches
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combined with comprehensive care models (antenatal care, social services, and substance use
treatment) are also showing promising results, such as increased prenatal care visits and patient
satisfaction, improved coordination of care, and decreased drug and alcohol use (Goodman,
2015; Lander, Marshalek, & Sullivan, 2016; Marcellus, MacKinnon, Benoit, Phillips, & Stengel,
2015; Nathoo et al., 2015; Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, &
Boyajian, 2013). These programs have been found to be feasible, yet they are resource-intensive
and are often located in urban academic medical settings (Mittal & Suzuki, 2015). While access
to integrated care models may be limited in rural areas, coordination of community-based
services is possible with careful planning (Jumah, Graves, & Kahan, 2015; Meyer & Phillips,
2015). The principles of harm reduction include strategies for reduction of the negative impact of
substance use as well as advancement of the rights of people who use substances (Harm
Reduction Coalition, n.d.). Such a philosophy requires care providers to set aside their own
opinions and emotions regarding substance use and instead focus on re-engagement of the
woman moving forward (Bartlett, Brown, Shattell, Wright, & Lewallen, 2013).
Programs for perinatal substance use disorders described in the literature have used a
variety of interventions, including integrated prenatal and substance abuse services and
motivational incentives (Ordean & Kahan, 2011; Ordean, Kahan, Graves, Abrahams, &
Boyajian, 2013). Additionally, women and providers may perceive effectiveness of program
components differently, so it is unclear which aspects of a harm-reduction approach contribute to
outcomes (Kruk & Sandberg, 2013). A focused review of the literature, highlighting studies of
perinatal substance use disorders that included health care provider-mother-infant relational
perspectives within various care delivery models, concluded that published studies have yet to
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identify the relative contribution of multiple risk factors to adverse outcomes as well as program
components most likely to improve outcomes (Kramlich & Kronk, 2015).
Pregnancy is often the impetus a woman needs to seek treatment for substance use
disorder, providing an opportunity for health and social care providers to engage these women
(Krans, Cochran, & Bogen, 2015). Covington (2008) suggested that women-centered approaches
to addiction and recovery should be gender-responsive, focusing on fostering connection
between healthcare providers and the women. She described a model of integrated care for
women framed in part by relational-cultural theory, which emerged from the work of Jean Baker
Miller in the 1970s (Comstock et al., 2008). Relational-cultural theory posits that healing
relationships are contextual, grounded in cultural and social identity, and that fear, shame, and
mistrust challenge the development of connection (Comstock et al., 2008).
Identification of maternal substance use and engagement in treatment have been found to
be challenging. Research has shown continued misunderstanding and negative attitudes of
healthcare providers toward pregnant women with substance use disorders (Benoit et al., 2014;
Maguire, Webb, Passmore, & Cline, 2012; Murphy-Oikonen, Brownlee, Montelpare, & Gerlach,
2010). Pregnant women with substance use disorders may delay or completely avoid seeking
substance use treatment due to fears of judgmental or uncivil care provider reactions (Metz,
Kochl, & Fischer, 2012). Some studies have indicated that universal screening of all women for
drugs and alcohol may reduce socioeconomic and racial disparities, resulting in improved
identification (Casper & Arbour, 2013; Eichel & Johannemann, 2014; Roberts & Nuru-Jeter,
2011), while others have suggested that fear of negative consequences related to discovery may
preclude women from seeking prenatal care (Roberts & Nuru-Jeter, 2010). Societal stigma, low
literacy levels, socioeconomic constraints, lack of resources, and rural healthcare disparities,
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specifically those related to poverty, further complicate engagement and access to treatment and
contribute to the negative outcomes for both mother and child (Alto & O'Connor, 2011; Jumah,
2016; Lander et al., 2013).
Social determinants of health, defined by the World Health Organization (WHO) as “the
conditions in which people are born, grow, work, live, and age, and the wider set of forces and
systems shaping the conditions of daily life” (WHO, 2017, para. 1), have been shown to impact
both substance use and perinatal outcomes (Centers for Disease Control and Prevention [CDC],
2011; Kim & Saada, 2013). Women living in rural areas tend to have lower rates of early
initiation of prenatal care, higher rates of pregnancy complications, and higher infant mortality
rates than their urban counterparts, even when controlling for substance use (American College
of Obstetricians and Gynecologists [ACOG], 2014). Additionally, socioeconomic disparities,
such as poverty, unemployment, and low education level, which are more prevalent in rural
areas, are associated with late or inadequate prenatal care and higher rates of adverse birth
outcomes (ACOG, 2014; Blumenshine, Egerter, Barclay, Cubbin, & Braverman, 2010; Phillippi,
2009). Access to prenatal care in rural areas is often hindered by lack of resources (finances,
transportation, childcare, availability); in women with substance use disorders, these barriers are
compounded by fear of judgment and losing child custody (Phillippi, 2009). Rural areas are also
much less likely to have adequate outpatient substance use disorder treatment services
(Cummings et al., 2014). Such barriers to treatment for pregnant women related to limited
accessibility and availability have been identified nationally (Jumah, 2016; Krans & Patrick,
2016).
The issue of maternal substance use and its negative impact on both the mother and the
infant persists despite numerous studies from multiple perspectives. Published studies have yet to
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identify the relative contribution of multiple risk factors to adverse outcomes as well as program
components most likely to improve outcomes. The voice of pregnant and parenting women with
substance use disorders seems to be largely missing in the literature as evidenced by the
comparatively limited number of qualitative studies. This focused ethnography aimed to address
that gap by exploring rural women’s experiences and perceptions of care to inform development
of efficacious, holistic models of care to improve outcomes for these women and their children.
Design and Method
As noted by Woodley and Lockard (2016), qualitative research methods may provide
more opportunities to engage with marginalized groups through personal connections as
compared to quantitative methods, therefore informing the choice of study design. Focused
ethnography, defined by Munhall (2012) as “the study of small elements of one society, group,
or culture; focus on [a] distinct problem within a specific context among a small group of
people” (p. 291), was particularly suitable for this study. The topics of inquiry for a focused
ethnography are pre-selected, and the short-term yet time-intensive nature of observations are
conducive to the study of sensitive topics and complex issues such as substance use disorders in
women during the postpartum period. Participant observations, oral accounts, and formal
interviews were used, with artifact review (media documentation of the sociopolitical
environment influencing the women’s care) woven into this data, to better understand: (1) the
experiences and perceptions of postpartum women with substance use disorders regarding the
care they received during their pregnancy and through their infants’ hospitalization; and (2) how
have their experiences supported or inhibited their ability to bond with their baby.
This study was conducted at a large tertiary care hospital serving the northern two-thirds
of a state in the northeastern United States, an area encompassing seven counties and nearly
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25,000 square miles. The majority of these counties are identified as rural as defined by the
Federal Office of Rural Health Policy (Health Resources & Services Administration, 2017).
Towns located in the farthest reaches of the service region are situated nearly 200 miles from the
hospital. This area is known to have one of the highest rates of opiate addiction in the country,
with over 12% of live births identified as substance-exposed (Hayes & Brown, 2012; Ko et al.,
2016). The area is also identified as having the lowest population density and highest rates of
poverty in the state and a Native American population greater than five times the national
average (Maine Center for Disease Control and Prevention, 2103; Maine Department of Health
and Human Services, 2008; Maine State Planning Office, 2012), factors noted to be barriers to
access to adequate resources for substance use disorder recovery, pregnancy, and parenting
support (Center for Substance Abuse Treatment [CSAT], 2009).
Institutional Review Board (IRB) approval was granted by the hospital to conduct formal
interviews with participants, informal conversations with non-participants, and observations of
the care environment and processes. Letters of agreement for participant recruitment were
obtained from directors of agencies and practices where potential informants were to be
recruited. Women were recruited for study participation in two ways, either through
informational flyers shared by their prenatal providers or by the inpatient perinatal social
workers after delivery. Women were offered a $25 gift card to a local department store to
participate in the study, received upon completion of the formal interview and data collection.
Written informed consent was obtained from participants upon initial contact and reaffirmed
verbally with any subsequent interaction. Health Insurance Portability and Accountability Act
(HIPAA) release was also obtained prior to review of any agency records. Information sheets
explaining the study were distributed to all staff involved in the care of the prospective
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informants. Verbal consent, supplemented with information sheets, was obtained from persons
not directly involved in the study but who became part of the data collection through their
interaction with prospective informants (such as friends and family members).
Women to be included in the study must have been pregnant (if recruited through
prenatal practices) or have recently given birth (if recruited through inpatient perinatal social
workers); English-speaking; at least 18 years of age and able to give informed consent; and had
an identified substance use disorder that included current use of an opioid (legally prescribed
medication assisted treatment, misuse of prescription opioid medications, or illicit opioids). A
total of 22 referrals were received over a 10-month period; of those potential participants, five
were deemed ineligible due to lack of personal history of substance use or already having
delivered their baby. Four other women were never successfully contacted due to unreachable
phone numbers, unreturned messages, or full voice mail-boxes despite multiple attempts. One
potential participant, whose first baby was transferred to the tertiary care hospital from a small
rural hospital, anticipated transfer of her second baby after delivery, as well. The practice
changed, however, and her baby was retained for observation at the small hospital, therefore
exempting her from participation.
Thirteen women were subsequently consented and interviewed, ranging in age from 22 to
40 years, with diverse demographics in terms of race/ethnicity, relationship status, child custody,
and stage of addiction recovery (Table 1). Nine of the interviews were conducted shortly after
delivery, during the five-day NAS observation period, with the remainder conducted nine days to
five weeks postpartum while the infants were receiving pharmacologic therapy for NAS. Only
about half of the women described living in stable housing with their partner and any other
children. Five of the women were living with extended family or friends, one temporarily. Six of
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the state’s 16 counties were represented, covering a geographic area of approximately 20,000
square miles, more than half of the state. Ten of the 13 women were multiparous and were
therefore able to compare their current experiences with those of previous pregnancies. Five
women had one or more psychiatric diagnoses that included depression (5), anxiety (4), bipolar
disorder (4), and post-traumatic stress disorder (2); three of those women had also been
diagnosed with attention-deficit/hyperactivity disorder.
Semi-structured interviews were conducted by the principal investigator in the mother’s
or baby’s hospital room and typically lasted 30 to 40 minutes. An interview guide, adapted from
Spradley (1979), was used to start with broad, open-ended grand tour questions focusing on
treatment and care received during pregnancy and eventual hospital experiences; subsequent
questions were based on answers to the grand tour questions. Interviews were digitally audiorecorded and transcribed verbatim by the researcher. Observations ranged from broadly
descriptive of the general hospital environment to more narrowly focused and selective during
participant interviews and were recorded through handwritten fieldnotes. The researcher was
denied access to the full electronic health record, so limited demographic data were gathered
from existing paper records. Other material artifacts, such as informational literature and
educational brochures that may have been relevant to the study, were not found in public areas.
Visual media reporting on the impact of perinatal substance use was collected and served to
augment the formal interviews and observations. All protected health information was deidentified and each case was assigned a computer-generated random code which was used on all
digital files, transcripts, fieldnotes, and journal notes to maintain participant confidentiality.
Informed consent and HIPAA forms were stored separately from interview transcripts and all
other forms of data.
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Framework analysis was used to analyze all data, including transcripts, typed fieldnotes,
and material artifacts, using various functions in Microsoft® Word, aided by NVivo 11®
computer-assisted qualitative data analysis software. Data analysis proceeded according to the
stages of framework analysis as described by Ritchie and Spencer (1994).
Stage 1: Familiarization through immersion in the data
Prior to transcription, recorded interviews were listened to for elements of speech, such
as intonation, stress, tempo, rhythm, pause, pitch, and register. Typed fieldnotes and
transcriptions were reviewed and proofed against handwritten and recorded data for accuracy and
served as preliminary analysis to guide subsequent data collection and analysis. Transcripts and
fieldnotes were read completely several times to get a sense of the whole (Sandelowski, 1995).
Digital and material artifacts, such as news accounts, were also gathered and reviewed for
relevance to the study. Jottings in margins served to create initial potential codes.
During this stage of familiarization, initial random coding of the interview transcripts
revealed 25 emerging concepts. Phrases exemplifying the concepts were extracted from the
transcripts and served as a catalyst for identification of a thematic framework. A key word count
was conducted using the “find” function in Microsoft® Word; dictionary definitions aided in
identification of synonyms and reduced the list from 25 to 13 concepts. Eighteen theoretical and
philosophical approaches to care in this population, informed by the literature review, prefieldwork conducted by the researcher, and consultation with the dissertation committee chair
and external member topic expert, were considered in the development of the thematic
framework (Stage 2).

124

Stage 2: Identification of a thematic framework
As noted by Pope, Ziebland, and Mays (2000), “key issues, concepts, and themes by
which the data can be examined and referenced [are identified] …by drawing on a priori issues”
(p. 116). In this stage, findings from the literature and pre-fieldwork conducted by this researcher
guided development of a thematic framework. Theoretical constructs and themes identified in
previous studies were used to develop labels for subsequent data categorization, the researcher’s
“etic” interpretation of the data.
Five theoretical and philosophical approaches were culled from the initial list based on
the congruence of the theoretical constructs with the emerging concepts. Through an iterative
process of comparing the terminology between the theoretical constructs and the emerging
concepts, three of the approaches, harm reduction, relational-cultural theory, and maternal-infant
bonding, surfaced as a sufficient thematic framework to categorize the data. Subsequently, a
codebook was created to begin Stage 3, the process of indexing the data.
Stage 3: Indexing – thematic framework applied to the data in text
Index headings were created from the thematic framework and then applied to units or
segments of data that appeared significant or relevant. Passages of data were highlighted and
color-coded notes were made in the margins of transcripts, fieldnotes, and print artifacts.
Annotations and analytic memos assisted with this process and subsequent comparison within
and between cases.
Stage 4: Charting through data matrices
Data matrices were developed from the coding schema to organize and display
categories. Substantive categories reflect the “emic” view, informant perspectives in their own
words taken from recorded data. Abstraction and synthesis of verbatim text was then
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summarized and passages were entered into charts to assist with subsequent mapping and
interpretation.
Stages 3 and 4 (Indexing and Charting) proceeded almost simultaneously; as the
transcribed and artifact data were reexamined through the lens of the coding themes, data
matrices and summary charts were developed. Concurrently, a list of initial impressions was
developed to solicit feedback from the ten participants who consented to being contacted after
the culmination of data collection. From that list, a feedback letter to participants was created in
a more readable and welcoming format. This process assisted in further refinement of the
themes, as it became apparent that both facilitators and barriers or challenges existed within each
of the themes.
Stage 5: Mapping and interpretation to find patterns, relationships, and explanations
The data matrices were further reviewed for themes and searched for patterns and
possible explanations for barriers to and facilitators of care in this population. The original aims
of the study and concepts generated from the data influenced this process, as suggested by Heath
et al. (2012).
Validity of the data, also known as trustworthiness, authenticity, and credibility, was
addressed through strategies described by Maxwell (2013). The principal investigator has
experience with the population of interest but was relatively unfamiliar with the study setting,
which may have reduced any researcher bias. Additionally, a reflective journal served to both
document analytic decisions and identify possible personal biases. Data was collected from a
variety of information sources (interviews, observations, artifacts) to build justification of
themes; documentation and analysis of that data contained thick, rich description. Data matrices
developed for data retrieved from all sources were shared with the dissertation committee chair,
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and discussions with the chair and methods expert assisted in validation of impressions and
search for any negative or discrepant information. Ten of the 13 women consented to follow-up
after discharge; a member checking letter was sent to those 10 women, with only one response,
and she concurred with the findings. Informational redundancy was recognized by the tenth
interview; three additional interviews produced no new themes, and therefore data saturation was
reached.
Findings
Participants described both supportive and challenging care experiences they encountered
for their substance use disorder, their pregnancy, and their subsequent delivery and participation
in their baby’s care. Their experiences and perceptions of care uncovered three domains with
underlying themes: challenges of getting treatment and care (i.e., service availability, distance
and geographic location, transportation, collaboration and coordination among providers,
physical and emotional safety), opportunities to bond (i.e., proximity, information), and
relationships (i.e., respect, empathy, familiarity, inclusion, interactions with care providers).
Challenges of Getting Treatment and Care
This domain focuses on the women’s narratives of the challenges they encountered in
seeking substance use disorder treatment and pregnancy care; arranging and getting to
appointments once they did find treatment and care; and dealing with multiple providers, often in
separate locations. The women also recounted situations that helped them overcome any personal
and logistical challenges they might have faced. The harm reduction literature provided a
framework for themes that emerged within this domain.
Waiting to get treatment. The 13 women interviewed shared numerous challenges to
accessing treatment, most notably with respect to availability of providers, compounded by
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distance, transportation, and coordination of services. Five of the 13 women spoke of the
challenges to access to treatment related to the lack of available services, insurance issues, and
long waitlists. Three of these women had been trying to get into substance use disorder treatment
for months; they gained immediate access once they became pregnant because they were then
Medicaid eligible. As one woman noted, “you had to wait”; another stated, “it was impossible to
get anywhere, and as soon as I got pregnant I got everything I possibly could need.” The third
woman became incarcerated during a six-month waiting period; she did not discover her
pregnancy until several months into her incarceration, and then she could not receive treatment
until she was released several weeks later. The three other women sought treatment early in their
pregnancies, and their access was expedited, as exemplified by the comment “I was the first one
they called because I was pregnant.” Expedited access due to pregnancy, however, did not
mitigate the lack of available treatment options; neither the one inpatient facility nor the handful
of outpatient services in the northern part of the state offered women-specific therapy. Only one
integrated program for pregnant and parenting women, with specialized substance use disorder
treatment, mental health, and social services co-located within a perinatal care practice, was
available in this area.
Geographic location is hard. Six of the 13 women lived in the county where the hospital
and most services are located; the remainder traveled up to three hours for their appointments.
Barriers presented by distance and geography (remote rural areas, only 10% of the state’s public
roads are major roads, many in poor condition) are illustrated by the comment “living an hour
away is definitely hard.” Women who received separate substance use disorder treatment and
perinatal care services in different locations faced additional challenges, regardless of where they
lived. One woman living in a different county stated that she received her services in “two
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separate places…it was hard.” Another woman traveled 40 minutes to receive treatment and care
in two different offices but stated, “it worked out pretty well ‘cause they’re not that far away
from each other.” The women’s perceptions of any barriers related to distance and location
seemed to be influenced by other factors, such as transportation and relationships with care
providers. One woman noted, “I live in [hometown], so it was 45 minutes away, which made it a
little difficult, but definitely worth it”, while another woman who lived two hours away offered,
“I do have the option to go somewhere closer to home, but I don’t want to, I really like where I
am.” Three other women traveled long distances for treatment and care by choice due to lack of
confidence in providers close to their homes. One woman described feeling “like you’re going
back 30 years”, while the other two perceived a lack of adequate knowledge and technology.
Transportation is a struggle. Ten of the 13 women talked specifically about
transportation issues, such as limited options and variable quality. Due to its rural nature, the
state’s public transportation system consists of unlinked transit services, a centralized nonemergency transportation scheduling system for persons with disabilities or low income, and
reliance on volunteers. Public transportation for these women is typically coordinated by two
non-profit social service agencies with mixed reliability and convenience. Four of the women
stated they had no public transportation options, while four others described it as “unreliable.”
Women described a variety of transportation challenges irrespective of geographic proximity to
care providers: delays in receiving approval for free transportation and filling the gaps with rides
from family and friends; arranged transportation that arrived too early, too late, or not at all;
weather-related transportation cancellations; refusal of city buses to go to one of the substance
abuse service agencies due to safety concerns; navigating public transportation with small
children and their gear in tow; and having to pay cab fare home because appointments ran late.
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As one woman plainly stated, “it’s been a struggle with transportation, especially not having a
license..., having anxiety and PTSD (post-traumatic stress disorder) not able to take the
bus…some days, like snowstorms or whatever, they cancel…the bus stops at 6:00…and I would
have to take a cab home.” Her experience was echoed by another woman who stated, “for
somebody that couldn’t handle for whatever reason doing [public transportation], what, a cab?
For me, that’s $3 every time…unfortunately, a lot of my family doesn’t know, so my option is
taxi.” Two women who were new to the area weren’t aware of available options; one stated she
didn’t know about [non-emergency transport service], while the other (who lived almost an hour
away from the hospital and received treatment and care from two practices 40 miles apart)
wasn’t aware of bus transportation. Since the two women had not established social contacts in
the area and did not have cars or driver’s licenses, private transportation was extremely limited.
Despite the challenges, three women expressed relief that they had some form of transportation,
as conveyed by the statement, “I didn’t have to worry about rides, and [non-emergency transport
service] was helpful, too, because they made it so I could actually get there.”
Collaboration and coordination among providers. Six women who received treatment
and care in separate practices for their substance use disorder and their pregnancy encountered
varying levels of collaboration and coordination among care providers. Two of the women
expressed satisfaction with the level of collaboration and coordination between their providers.
As one stated, “they seemed to coordinate very well”, while another noted that both practices
worked together to accommodate her schedule. One woman who was told by her long-time
provider that “if I got pregnant again he couldn’t see me anymore” described being pleasantly
surprised to discover that he facilitated transfer of her treatment and care to two new providers,
one with whom she was already familiar; as she said, “I didn’t have to do anything, like he made
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all the appointments for me, he did all the referrals, he took care of everything…that was
awesome.”
Even women who expressed satisfaction with their providers found mixed collaboration.
For example, one woman indicated that her obstetrician and substance use disorder provider did
not discuss adjustments of her buprenorphine dosing. She found that her dose had been increased
due to reported hip discomfort, without her or her obstetrician’s knowledge, stating that her
provider “just wanted to make sure she was getting through the night OK.” Subsequently, her
obstetrician would ask “she didn’t change you again, right?” Another woman had a similar
experience in a different location, where decisions to increase her buprenorphine dose were not
discussed with her or between her prescriber and her obstetrician, and both providers relied on
her to relay information between them. One woman described a lack of communication and
collaboration among obstetric providers within the same practice, noting that lab tests were
repeated or omitted and the tubal ligation for which she consented with her elective repeat
Caesarean section was overlooked. A third woman simply stated, “they didn’t really
communicate (with one another).”
Coordination of appointments at separate practices was also variable. One woman stated
that “they seemed to coordinate very well” in scheduling her appointments and found “it wasn’t
that big of an inconvenience.” Another woman noted that while attempts were made to schedule
her appointments on the same day, “sometimes that didn’t happen”, while a third woman
asserted “basically I did it by myself.”
Seven women received integrated care through a program where specialized substance
use disorder treatment, mental health, and social services are co-located within a perinatal care
practice. Care is coordinated by a core group of physicians and an advanced practice nurse.
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These women expressed great satisfaction with their care, all using words such as “easy” and
“convenient.” One woman stated that “it made it so much easier, you know, to be able to just go,
and the same doctor I was seeing for my pregnancy was the same doctor that was prescribing me
the Subutex.” None of these seven women had previously received both substance use treatment
and prenatal care where services were not integrated; one woman received prenatal care for two
prior pregnancies in another state and had not sought substance use treatment, instead actively
using illicit substances throughout those pregnancies. She did not elaborate on her reasons for
not previously seeking substance use treatment other than to say it was “different” where she
came from, that she felt “looked down on” there. She talked about how being able to get her
treatment and care in the same place where she also felt no judgment facilitated honesty and
attendance at her appointments.
Fears for physical and emotional safety. Women shared some of the fears they
overcame to seek treatment. Two of the women described a specific substance abuse treatment
facility where they felt unsafe due to the mixed population and fights among the clients, further
complicated by the refusal of the city buses to transport clients to that location. One woman
spoke of feeling grateful that she was not referred to that facility and instead was in a practice
where she felt safe, “‘cause that was my biggest fear of getting help.” Another woman contrasted
her experiences between that facility and where she received substance use treatment during her
pregnancy, a place she stated she knew was safe. Her ability to change practices was unusual as
few treatment options for substance use disorder are available in this area, and due to limited
capacity, it is nearly impossible to transfer to a different practice once treatment has been
established. She talked about her fear related to interaction with the clients at the former facility;
she described them as “enemies” and “triggers” for her. She attributed her ability to resist relapse
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to the physical and emotional safety she felt with her current provider. In contrast, and despite
the physical safety challenges, another woman continued treatment for her substance use
disorder at that facility through two pregnancies. Her emotional safety seemed to outweigh any
physical threats she felt; as she stated, “they worked around my schedule; it made it easier, and
not one of the doctors judged me, and that absolutely helps.”
Five women suggested that the emotional safety and trust they felt allowed them to be
honest, which, as one woman noted, “got me better help.” Women with multiple pregnancies
described contrasting experiences with respect to emotional safety. For example, one woman
talked about not being honest about her substance use to providers in another state because “I
was looked down on, I was talked about, I was treated differently, which makes you really not
want to say anything.” During her most recent pregnancy, she stated she was honest because
“nobody ever treated me different…even when I did slip, I did fall, I did use, I never was looked
at weird or talked down to.” Another woman reported numerous instances of feeling judged and
dismissed, false reports, gaps in care, and miscommunication that left her feeling mistrustful of
her providers with both of her pregnancies (one out of state, the current pregnancy in Maine).
She talked about wanting to stay clean and stated, “if I wasn’t thinking right I would have gone
back to drugs because that (mistrust) was a trigger for me.” She stated she didn’t like the prenatal
practice for those reasons but she stayed “because it was already too late for me to just go to
another one.” Despite those experiences, she talked about being positive and not changing
practices because “I don’t want to start all over again because I’m scared that I go back, that I
don’t have that strength to just express myself again from the start.” She spoke most positively
about her substance use treatment provider as she stated, “I can be open and talk to him about
anything and trust him a lot…he’s doing a good job ‘cause I been clean for a year.”
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Opportunities to Bond
This domain speaks to the women’s descriptions of aspects of care that either supported
or inhibited opportunities to bond with their babies, themes which are also found in the maternalinfant bonding literature. Proximity was contingent upon factors such as distance from hospital,
physical environment, and resource availability. Women sought complete and accurate
information to prepare for immediate newborn care and transfer home. They reported varying
degrees of self-efficacy and participation in their baby’s care.
Being with the baby. Twelve of the 13 women were with their babies during the
interviews; seven of those 12 were rooming in, while space and double occupancy allowed for
only visitation for the other five. Observed interactions with their babies varied; one woman
breastfed her baby through the entire interview, three provided basic care (diaper change,
swaddling), two held and rocked their babies during the interviews, and the remainder allowed
their babies to sleep in open cribs but stopped to check on them frequently during the interviews.
Four women indicated that their presence and active participation in their baby’s care seemed to
alleviate their baby’s distress as exemplified by the comment, “the longer I would be away from
him, he would start showing more agitation and irritability.” Another woman noted that her baby
seemed to feed better for her than for the staff when she left for the night; as she stated, “when
I’m here during the day he holds all his bottles down… he really doesn't puke besides when he's
with them.” The woman who lived three hours away described cutting short a necessary trip
home because her baby’s withdrawal symptoms were escalating; she believed her baby’s
condition improved as soon as she returned and assumed care.
Distance between home and the hospital proved to be challenging for the seven women
from other counties. As an example, one single mother with a school-aged daughter described
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the difficulty of being away from home for a month, stating, “I haven’t left her (her new baby),
you know, I’ve been here for God knows how many days, 30 something days.” Three women
expressed fear that they might have had to deliver their babies at their local hospitals, which
were not equipped to care for substance-exposed newborns. In such cases, their newborns would
have been transferred to the larger hospital without them. As one woman noted, “I didn't
honestly think I was going to make it. I thought I would have to go to [small hospital closer to
home], and you know I wouldn't be able to be with him. It was hard.” The other two women
offered similar concerns that their babies would have been transferred without them; one stated,
“I’m not OK with that.”
Options allowing parent cohabitation with their babies, known as rooming-in, became
more available with the opening of the new NICU at the large hospital. The new NICU was built
with all private rooms, pull-out cots, private bathrooms and showers, individual breast pumps,
and breast milk refrigerator/freezers. The five women interviewed on this unit described the
comfort and ability to stay with their babies; three of those five women were multiparous and
could compare the improvements with their prior experiences. In contrast, the eight women
interviewed prior to the opening of the new NICU were limited in their ability to room in with
their babies due to space constraints and transfer to semi-private rooms. As one woman noted,
“it’s uncomfortable and difficult to stay here with your baby.” Another stated,
there's no room upstairs so he had to stay here and I can't be here with him so I try to be
here with him during the day and go home at night and sleep and, you know, which stinks
really bad because I hate leaving him.
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One multiparous woman was interviewed in the old continuing care nursery (lower-acuity
intermediate care unit) just prior to the opening of the new NICU; she observed and commented
on the construction, stating,
Do I think that these rooms are set up to have families room in with them? No. I really
think you guys have it right on point that their new wing or development, what they're
doing so that it is comfortable for people to stay right there with them is the most
important.
Not always feeling prepared. Eight of the women described gaps in their knowledge and
understanding of the impact of their substance use on their babies. Even women with prior
experience seemed unprepared for their babies’ withdrawal symptoms and possible need for
pharmacologic therapy. Women offered comments such as “nobody really prepared me for this”,
“I didn’t know what to expect”, “they didn’t tell me how bad it could get”, and “getting that
phone call saying we’d like to start methadone was still a shock to me.” One of those women
said she was told that “within 5 to 7 days she’d be home and she’d be fine”; her baby required
pharmacologic therapy and an extended hospital stay. Two women described getting information
from friends or online searches. Only two of the eight women stated they felt well-informed and
prepared for the required observation period and the potential for their babies to withdraw.
Information, education, and communication regarding newborn care seemed variable.
Although the four first-time mothers expressed feeling well-informed and prepared for discharge
(“they definitely go through and cover everything before they let you go home”), two of the
women with other children were feeling ill-prepared for the challenges they were facing, such as
how to console their child. The one woman whose baby was not present during the interview felt
she had to send her baby to the nursery because she “didn’t know what to do with him, they’re
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not really helping me.” Two women spoke specifically about not being informed about key
aspects of their baby’s care, such as time and amount of prior feeding. Observations conducted in
the inpatient care settings seemed to validate the women’s impressions. Dry erase boards
commonly used in patient rooms for communication were noted to be blank or not updated, and
these study interviews were frequently delayed or interrupted because the women were trying to
track down information necessary for their baby’s care. Three women suggested that information
was readily available if needed, although one woman felt that unless education was mandatory,
most women would not take the time to ask. One woman stated, “whether you choose to know, if
there’s a question you have, I pretty much feel I could ask.” Another advised health care
providers to
Just try to be understanding as far as the parents' concerns and their questions and try not
to be judgmental. Um, 'cause then that makes the parents feel awkward and then they're
not going to ask what they need to. And it's important that they can feel comfortable to be
able to ask what they need to, 'cause otherwise they don't know what they're doing when
they go home.
Relationships
The relationship domain encompasses the women’s accounts of respect, empathy, and
inclusion (or lack thereof) as well the importance of familiarity with care providers, which
exemplifies relational-cultural theory. They all shared examples of interactions with providers
that exemplified respect for their choices, personal respect, understanding of how hard addiction
and recovery are, and inclusion in decisions regarding their own care and care of their baby. This
theme spans both prenatal care and postpartum hospital experiences.
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Respect and judgment. Relationships with health care providers that included respect
and understanding seemed to be most important to the women and often mitigated burdens such
as distance and transportation. All the women manifested signs of internal stigma, referring to
themselves as “addicts” and speaking of feeling guilt, shame, and embarrassment. As one woman
stated about her previous experience, “people were very judgmental…that’s a big thing, you
know, the stereotype, and you already feel shitty enough.” Despite transportation challenges, she
continued with her current providers because none of the providers judged her; “it’s challenging,
but we made it work.” Another woman described her challenges regarding distance,
transportation, and substance use treatment and prenatal care in separate practices, and yet she
persisted because of her relationships with her providers, stating, “times I thought I would
relapse, I talked to my clinician and she’s amazing, I love her to death.” As noted by a third
woman, “I do have the option to go somewhere closer to home, but I don’t want to, I really like
where I am, I like the people that take care of us.” She added, “they don’t look at me and go ‘oh,
she’s a drug addict’…this place, I’ve never felt more like a human being in my life…I matter to
them.” Three women specifically mentioned feeling respected by the advanced practice nurse at
the integrated care program; one woman described her as “awesome, very awesome, she’s
fantastic”, noting that she lived 45 minutes away, “which made it a little difficult, but definitely
worth it.” As another expressed, “it was really hard to stay clean, but there was no judgment…
people who have been pregnant with substance abuse, everybody goes there because it’s really
good care.” The third woman stated, “she’s made a big difference in my life…she doesn’t treat
me like an addict.” Conversations between the principal investigator and the advanced practice
nurse corroborated the women’s impressions; she conveyed a sense of genuine respect and
empathy for the women for whom she cared.
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Women in the current study anticipated judgment by caregivers, and, in many cases, their
fears were not unfounded, as they recounted situations where they felt disrespected. One woman
recounted “rude” behavior by a nurse caring for both her baby and the other baby in the room
(who also had NAS), noting a contrast with how other women (whose babies did not have NAS)
were treated. She stated, “I left a couple of times in tears.” A woman who described particularly
traumatic prenatal and birth experiences said she was told “we don’t want to do a C-section
because you were a junkie and we don’t want to give you drugs” even though she had been in
recovery for over three years. She went on to say that it “made my first experience having a baby
miserable.” She contrasted her prenatal experience with her inpatient interactions; she noted “I
felt like people were gonna judge me because I put her here…but this place is amazing.” Another
woman stated that “having NAS on my file and stuff, I felt not as well treated” on the labor and
delivery unit. She described feeling “so guilty and so horrified, I felt like a horrible person, I felt
like a horrible mother.” Two other women described similar experiences of feeling “looked
down on” and “talked down to” because of their substance use; as one woman stated, “if I give
respect, I should get respect back, and I don’t think nobody should talk me down, talk to me like
I was a nobody.” She implied a willingness to endure less respectful behavior if her baby was
well cared for, indicating that she overlooked some of the hurtful comments (“I just put my head
down and I just walked away”). She stated several times that she was trying to focus more on the
positive than the negative and was grateful for nurses and volunteers “taking their time to just
care about the baby.”
One specific NICU nurse was referred to by two women as caring and taking the time to
talk with them; as one woman noted, “we felt very comfortable with him, he lightened the mood
by joking, I mean, it just really raised our spirits.” During observations, this nurse seemed to take
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an active interest in the study and spent time to converse with the principal investigator on
several occasions, always speaking respectfully about the women. His observed interactions with
the women were patient and kind, and the women appeared comfortable with him. This
contrasted with other observations where staff interactions with the women seemed brief and
limited to necessary tasks. No conclusions could be drawn from these limited observations as the
environment did not allow for general observation of interactions with women not included in
the study.
Three women spoke positively about the chief pediatrician’s influence on the care they
received. One woman described his advocacy for her to stay with her baby and relieving her
guilt. Multiple discussions with this pediatrician by the principal investigator seemed to reinforce
the women’s accounts. His regard for the women has been well-captured in a video documentary
(YoungParentsLearnTogether, 2011).
Understanding the challenges. Five women offered their opinions that providers and
caregivers need to understand how hard addiction is and that women are doing their best to stay
in recovery although they sometimes make mistakes. They shared that they already feel guilt and
shame, and they asked that they not be criticized or judged, noting that such attitudes would
discourage women from being open and honest. One woman admitted to “having slips” and
described her prenatal providers as “understanding about everything”; as she stated, “when I did
slip, I did fall, I did use, I never was talked down to.” Another woman attributed her ability to
avoid relapse to the support of her provider.
Four of the women described the challenges of having other children to care for and the
lack of family accommodations. Two women specifically spoke to a lack of understanding about
limitations in their presence at their baby’s bedside due to responsibilities for their other
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children. As one woman stated, “she complained I wasn’t here early enough, she’s like ‘all I’ve
been doing is changing his diapers all morning’…I’ve got other kids, I have to take care of them
too.” During one observation, a nurse was heard to exclaim loudly that “she had four NAS babies
screaming their heads off and their mothers aren’t here”, the reasons for which were not
divulged. Conversations between the principal investigator and the two social workers revealed
the challenges faced by the women and their impression was that it takes great courage for the
women to overcome barriers in order to be present and care for themselves and their babies.
Seeing different providers. One woman who was required to change practices with her
third pregnancy expressed concern about having to establish new relationships and described her
relief and gratitude that her previous provider facilitated transfer to a new practice that included
familiar and trusted providers. Another woman who was also required leave a familiar practice
upon becoming pregnant spoke of the initial adjustment and “getting used to the new providers.”
A woman with three children who had been in recovery for over 10 years and had maintained the
same providers recounted being “shuffled around and bounced around” initially, which made her
feel uncomfortable due to the “stigma that comes with being an addict.” She was “pretty adamant
that I see the same three people”, including one advanced practice nurse who “doesn’t treat me
like I’m an addict…there’s been some trust built up and I’m open with her about things.” Two
women described a level of discomfort with frequent changes in health care professionals both in
their prenatal practices and in the hospital setting. As one woman noted, “having different nurses
constantly is kind of a pain in the butt because you’ve gotta get to know someone new every
shift.” This sentiment was echoed by another woman when she said, “each day there’s a different
doctor, and two different nurses for each shift…that’s four nurses a day, and every one of them
has a different way of doing things.”
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Feeling included. Two women related specific instances where they felt included in
decisions about their own treatment and care. As one noted, “they don’t try to pressure you into
doing anything…they’ll sit there and talk to you, and if it’s something you don’t agree with, they
won’t push it.” One woman noted that her substance use disorder treatment provider adjusted her
medication doses only after discussing it with her; another woman found that her doses had been
adjusted without her knowledge, which “kind of bothered” her. Five women described inclusion
in choices regarding where they would deliver their babies, frequency of visits for substance use
disorder treatment, and aspects of the baby’s care regarding medication-assisted withdrawal.
Women described contrasting experiences in regard to feeling included in their baby’s
care. As one woman stated:
I definitely feel included, I definitely feel welcomed, I feel like when we're here they
basically, you know, "do you need anything? no, OK, we're gonna let you do it". And
that's what I want, I mean, I want the offer of help and know that it's there if we need
them. But I also want to be a parent to my child.
Another woman described a different impression; she spoke of feeling that her choices were not
respected, saying, “every nurse and doctor is different…and every one of them has a way of
doing things, and then there’s your way of doing things. I’ve tried to learn their ways…if you
don’t, it comes back at you.” She added that “if you don't do it their way, there is a couple that,
you know, aren't so nice.”
Inclusion in neonatal withdrawal scoring was variable. As noted by one woman, “I’ve
been right here with her and I do pretty much all of her care”, answering affirmatively when
asked if she was encouraged to participate in the NAS scoring. Another woman, whose baby was
born at a small hospital and had been transferred numerous times among three different units due
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to acuity and space issues, recounted her attempts to participate in withdrawal scoring being
largely ignored on several of the units. She felt this lack of inclusion contributed to at least one
of the transfers. She noted that nurses on one of the units did take the time to listen, stating, “they
respect me, make me feel comfortable.” A third woman wasn’t sure if her reports of her baby’s
symptoms were considered in the scoring.
Discussion
The purpose of this study was to add personal accounts to the literature regarding care of
rural women with substance use disorders through their pregnancy and early postpartum period
to address this gap in research. Formal interviews of the 13 rural women in this study revealed
experiences and perceptions of the care they received during their pregnancy and through their
infants’ hospitalization as both supportive and challenging. The women’s personal accounts were
supported by conversations by the principal investigator with health care providers; observations
of care environments and participant interactions with others in the context of care; and review
of artifacts, such as publicly available information.
The women in this study encountered limits in access for both their substance use
disorder treatment and pregnancy care, most notably regarding availability and insurance
coverage for services, often having to wait to get treatment. While these challenges may not be
unique to rural women, they are intensified by the lack of capacity related to too few willing
and/or knowledgeable providers in rural areas (Bishop et al., 2017; Rosenblatt, Andrilla, Catlin,
& Larson, 2015). This was demonstrated by the women’s descriptions of having to travel long
distances using sometimes unreliable transportation to access services or encountering perceived
knowledge deficits in their local care providers. These women all relied on public assistance for
their health care; specialty services for substance use disorders have been found to be more
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heavily financed by public sources, such as Medicaid (Cummings, Wen, Ko, & Druss, 2014).
The state where this study was conducted is one of the 19 states that did not expand Medicaid
coverage to low-income adults, which directly impacted three of the women in this study as they
described the long wait for treatment for their substance use disorder until they became pregnant.
Public assistance also impacts transportation options for these women. These challenges have
been outlined in numerous articles in the major local news media over the past six years as
funding has been cut and restrictions placed on eligibility and treatment duration (Appendix F).
In general, the women described gaps in information and their understanding of available
resources and the impact of their substance use on their babies. Paired with this lack of
information were variable degrees of inclusion in decision-making and the care of their
newborns. Women in a study conducted by Howard (2016) likewise noted a wide range of
information and inclusion with respect to their options. Evidence exists that maternal presence
and active involvement in decision-making and care result in improved maternal and newborn
outcomes (American Academy of Pediatrics [AAP], 2016; Boucher, 2016; Edwards & Brown,
2016; Holmes et al., 2016; McKnight et al., 2016). Six of the babies in this study required
pharmacologic therapy for NAS; three were deemed eligible for earlier discharge home on a
methadone weaning protocol, as opposed to a traditional inpatient methadone wean. The
woman’s active involvement in her baby’s care, with support from a multidisciplinary team, is
required for this outpatient treatment.
The women’s experiences and interpretations of how they were perceived by both
outpatient and inpatient care providers seemed to dominate the interviews. The women revealed
a willingness to accept inconvenience and logistical challenges to receive care where they felt
respected and understood. As noted by Marcellus and Poag (2016), these women “typically face
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significant negative attitudes, judgment, and stigma” (p. 327). Additionally, women chose to
travel longer distances from their homes to access treatment and care by providers they perceived
as more competent. Oser and Harp (2015) suggested that while stigma and rural cultural values
may inhibit utilization of substance abuse treatment and support resources, rural clients with
SUD may prefer treatment in a more urban setting for the perceived practice expertise, relative
obscurity, and reduced stigma. They used the term geographic discordance to describe the
phenomenon of “traveling from one’s home residence to a county with a different socio-cultural
context” to receive treatment and care (Oser & Harp, 2015, p. 77).
The women in the present study expressed feelings of guilt, shame, and embarrassment,
particularly when they talked about the effect of their substance use on their babies and the rest
of their families. Similar feelings were described by women in a recent study conducted by
Cleveland, Bonugli, and McGlothen (2016). In that study, as in the present study, the women felt
their presence and active participation in their baby’s care alleviated their baby’s distress.
Findings of new research suggests that newborns whose parents spent more time at their bedside
have less severe withdrawal symptoms and shorter hospital stays during treatment for NAS
(AAP, 2016). Women in the present study expressed fear of being judged by health care
providers based on their prior experiences or those of their acquaintances. Such fear and stigma
have been shown to be barriers to treatment and care, discouraging women from seeking and
engaging in substance use treatment and prenatal care, potentially increasing the risk of harm to
the mother and baby (CSAT, 2009; Stone, 2015). Judgment of pregnant women with SUD by
rural practitioners due to a lack of knowledge and experience regarding perinatal substance use
may be reduced through targeted education (Seybold et al., 2014).
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The personal accounts shared by the women were consistent with concepts gleaned from
the harm reduction, maternal-infant bonding, and relational-cultural literature. The women
touched upon elements of harm reduction strategies, including information and understanding of
available resources, access to services, collaboration among providers, transportation assistance,
and integrated care models, as they related both supportive and challenging care experiences. As
noted, 12 of the 13 women were with their babies during the interviews, whether they could
room in or not. They spoke of some of the challenges they encountered to be with their babies
and their belief that their involvement in their baby’s care was important. A qualitative study
conducted by Atwood et al. (2016) revealed similar themes, such as parental education and
preparation for NAS, parents as partners in care, interpersonal interactions and communication
with the health care team, and the hospital environment and transitions in care. The women
interviewed in the present study conveyed a need for connection, a basic tenet of relationalcultural theory, whether that be with providers and caregivers, other women in similar
circumstances, or their babies and other family members. They all expressed gratitude for the
opportunity to tell their stories and hoped the information they shared would be helpful to others.
They were emotional and often shed tears when they related episodes that seemed painful to
them. They wanted people to understand that addiction and recovery were hard; they were doing
their best despite the barriers; they took responsibility for their choices; sometimes other
responsibilities kept them from being with their babies; and judgment and disrespect were
triggers to relapse that also discouraged them from being honest. Five of the women had
diagnosed mental health disorders, including post-traumatic stress disorder; six others described
traumatic events that they felt contributed to their substance use disorders and relapses. Research
has shown that interactions not grounded in respect and empathy can retraumatize women,
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triggering relapse and impeding access to care (Boyd & Marcellus, 2007; Covington, 2008;
SAMHSA, 2014b).
Implications
The results of this study add the voices of rural women in the development of practices
and policies regarding access to substance use treatment, care provider education and training,
non-punitive approaches to substance use during pregnancy, and models of both prenatal and
postpartum care of the mother-infant dyad. As the rates of perinatal substance use disorders and
NAS continue to rise, nurses, other health care providers, and social and mental health
professionals need to be mindful of the unique challenges and complex needs of this population,
particularly in rural areas where services are limited. Legislation, such as the Drug Addiction
Treatment Act of 2000 (DATA2000), the Office of National Drug Control Policy
Reauthorization Act of 2006, the 2010 Affordable Care Act (ACA), and the 2016
Comprehensive Addiction and Recovery Act (CARA), has expanded substance use treatment
options that may benefit areas with limited substance use treatment providers. Office-based
physicians who have completed approved courses or have board certification in addiction
medicine (called “waivered physicians”) may prescribe buprenorphine maintenance therapy,
with patient limits recently increased from 30 to 100 per waivered physician (DeFlavio, Rolin,
Nordstrom, & Kazal, 2015; Stein et al., 2015). Section 303 of CARA extended buprenorphine
prescribing privileges to nurse practitioners and physician assistants who have completed 24
hours of required training, thereby increasing the number of providers and filling practice gaps in
rural areas (ASAM, 2017). Despite this expansion, providers have cited inadequate training as
the biggest barrier to adoption (DeFlavio et al., 2015). Learning collaboratives, utilizing
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teleconferencing across a wide rural geographic area, may provide a solution to that challenge
(Nordstrom et al., 2016).
While availability, accessibility, and affordability may impede substance use treatment in
rural areas, acceptability related to guilt, shame, and fear of stigma has been found to be a greater
barrier (Jackson & Shannon, 2012). The women in the present study demonstrated a willingness
to sacrifice convenience of services closer to home for substance use treatment and prenatal care
that was felt to be respectful and inclusive. Compassionate, women-centered approaches that
incorporate a harm reduction philosophy are key to successful care of these women (Sutter,
Gopman, & Leeman, 2017). The CSAT (2009) and other agencies (SAMHSA, 2016; WHO,
2014) have identified strategies to engage women with substance use disorders through
development of personal connections and trusting relationships. Additionally, several published
local, national, and international guidelines encourage parent education, anticipatory guidance,
and collaborative decision-making to improve care and outcomes for the mother-infant dyad
(Maine Chapter AAP, n.d.; O’Connor & Alto, n.d.; SAMHSA, 2016; WHO, 2014). Further,
programs for outpatient pharmacologic therapy for newborns withdrawing from opioid exposure
are showing promising outcomes with respect to length of stay and expenditures (Lee, Hulman,
Musci, & Stang, 2015); such a program has been available since 2014 in the area where the
current study was conducted, and three of the women’s babies were being discharged home
through this program.
More research is needed to explore the uptake of the new SAMHSA (2016) guidelines
and their subsequent effects on maternal and infant outcomes. Women in the present study,
particularly the six who received their substance use treatment and prenatal care through separate
practices, described their experiences of provider practices and interactions that were
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inconsistent with recommendations of the SAMHSA guidelines, such as lack of collaboration
and standardization of care. The comprehensive guideline promotes collaborative policies and
practices to “support the health, safety, well-being, and recovery of pregnant women with opioid
use disorders and their infants” (SAMHSA, 2016, p. 8), focusing on interventions that may
reduce the harm of perinatal substance use. The nurse’s role in the care of the woman and her
newborn in outpatient, acute care, and community-based settings is delineated in the guidelines.
Nursing research should focus on the most effective strategies in overcoming the welldocumented barriers to substance use treatment and prenatal care in rural areas, such as lack of
resources. The women in this study offered their perspective on their unique challenges as well
as suggestions for mitigating those barriers, specifically in regard to collaboration,
communication, and relationships. Further studies are essential to identify effective care delivery
models and best practices for staff training regarding perinatal substance use and care that is
nonjudgmental, standardized, and collaborative. Longitudinal studies would provide evidence of
factors that contribute to engagement in treatment and care, sustained recovery, and child
development. Research into the impact of changing public policy on women’s access to
treatment and care is also necessary.
Knowledge translation, defined as a “dynamic and iterative process that includes the
synthesis, dissemination, exchange and ethically sound application of knowledge to improve
health, provide more effective health services and products and strengthen the healthcare
system” (Straus, Tetroe, & Graham, 2011, pp. 6-7), provides a framework to support
improvement of care based on the research findings. The Rural Health Research Gateway
(https://www.ruralhealthresearch.org/), an online library of research and expertise supported by
the Federal Office of Rural Health Policy, Health Resources and Services Administration, U.S.
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Department of Health and Human Services, includes a toolkit for dissemination of rural health
research (Schroeder, 2015). The toolkit proposes guidelines for various modes of dissemination
and provides examples of effective use of products (e.g., policy briefs, fact sheets, publications,
and presentations) through social media, press releases, and media interviews. As noted by
Boydell, Stasiulis, Barwick, Greenberg, and Pong (2008), it is important that dissemination
strategies are adapted to the audience and specific community. This toolkit can be a valuable
resource for moving the findings of the present study into practice.
Study Limitations
Recruitment in this population was found to be challenging with respect to ethical
approval, participant eligibility and availability, practice changes, and discrepancies in the
recruitment process. To conduct this study, ethical approval from two Institutional Review
Boards (IRBs) was required, a process that involved two full board reviews and took nearly eight
months. Recruitment procedures seemed inconsistent for unclear reasons, and potential
participants were found to be ineligible or unavailable in nine of the 22 referrals. Despite several
amendments to the research protocol and expansion of recruitment methods and locations,
participant recruitment was limited to the tertiary care hospital and two local perinatal practices.
No participants were recruited for the present study from the rural county where communitybased services are coordinated to compensate for the lack of an integrated care model. Early
successes of the program, such as increased prenatal care visits and decreased hospital length of
stay for babies with NAS, have been reported (Morton, Withers, Konrad, Buterbaugh, & Spence,
2015), and the local hospital also expanded care for infants with NAS, both of which may have
accounted for the lack of participants from that county.
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Visits and frequent telephone and e-mail contact with key personnel by the principal
investigator did not seem to increase the potential participant pool. Conversations with outpatient
providers and inpatient social workers revealed potential challenges to recruitment, including the
women feeling overwhelmed with information about programs and services, multiple other
studies being conducted in this population, and women often not being present due to
transportation and/or other family obligations. Staff conceded that they often forgot to introduce
the study to eligible women due to workload issues, indicating that a number of potential
participants were likely missed.
Opportunities for substantial observation periods were limited due to hospital renovation
and new construction. The units lacked common public areas and family waiting rooms, and
prior to the opening of the new NICU, many patient rooms were semi-private. Hospital staff
requested that the principal investigator not linger in hallways or outside patient rooms to respect
the privacy of other families, so opportunities for observation of the general care environment
were confined to the nurses’ stations or chart rooms during collection of demographic data.
Additionally, as anticipated, the women were often fatigued, entertaining visitors, or had other
commitments that shortened the interviews and observations.
Data collection was limited to the inpatient setting, and therefore the women’s accounts
of their prenatal experiences were retrieved from memory and may have been influenced by their
current postpartum experience. Although women were given the researcher’s contact
information, and ten of the 13 women consented to follow-up, only one woman responded to the
member checking letter. Sequential interviews and observations over time, to include the
prenatal and post-discharge period, may have contributed valuable insights into the women’s
experiences.
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Selection bias may have been present due to the vulnerability of this population. Women
who consented to participate in this study either retained full custody of their newborns, had
relinquished custody to a family member, or were working on reunification. All participants
were aware of the state mandated reporting to the Department of Health and Human Services of
infants identified as being prenatally substance exposed (Child and Family Services and
Protection Act, 2003). Women who did not volunteer for participation in the study may have
feared child protective services investigation; therefore, results of the present study may not
represent the views of such women.
Conclusions
Substance misuse persists, and pregnant and parenting women with substance use
disorders continue to face stigma and barriers to treatment and care despite the mounting
evidence that addiction is a chronic relapsing medical condition (Terplan et al., 2015). Nursing is
the largest of the health care professions in the U.S., and nurses comprise the largest single
component of hospital staff (American Association of Colleges of Nursing [AACN], 2011).
Nurses’ scope of practice includes comprehensive assessment, collaboration with other members
of the health care team, development of patient-centered health care plans, and evaluation of
nursing interventions, all important components of care for women with substance use disorder
and their babies (Russell, 2012). Nurses connect with women in both community-based and
inpatient settings and, as such, can positively impact the care of these women and their babies
through provision of skilled, nonjudgmental care (Chu & Galang, 2013; McKeever, SpaethBrayton, & Sheerin, 2014; Shaw et al., 2016). Evidence and resources are available to provide
compassionate care. It is imperative that nurses become actively involved in development of
public policies to support collaborative, integrated models of care, reduce rural and poverty-
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related health disparities, and discourage punitive treatment of women that only serves to impede
their access to treatment and care.
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Table 1: Demographic characteristics
Characteristic
Age
Race

County

Marital
status1
Child
custody2
Pregnancy

Delivery

NAS Rx
Stage of
recovery3

Location in
hospital

Prenatal Care

Definition
Years
White
Black
Latina
Pen…..
Pisc…….
W….
A……..
H……
O…..
Married
Partner
Single
Full
Visitation
Relinquished
Unclear
Primiparous
Multiparous
SVD - term
SVD - preterm
Unplanned home delivery
Induced (IUGR)
Planned repeat CS
None
Pharmacologic (inpatient)
Pharmacologic (outpatient)
Uncertain (still under observation)
Adherent
Relapsing
Court-ordered residential treatment
NICU (old)
NICU (new)
CCN
MBU
Pediatrics
FMRP
WCHM
W…. County
A…….. County
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n = 13
29
(range 22-40)
11
1
1
6
2
2
1
1
1
2
7
4
9
1
1
2
4
9
6
1
2
2
2
4
5
2
2
6
6
1
2
5
3
2
1 (external transfer)
7
4
1
1

Table 1 Legend:
1. Marital status:
a. Partner: women referring to a partner, boyfriend, or fiancé; Maine does not have
common law marriage
b. Single: women stating they were single or divorced and not with the father of the
baby
2. Child custody:
a. Visitation: previous child in relative care with visitation rights
b. Relinquished: Previous children had been relinquished to child protective
services, working on reunification
c. Unclear: Custody of previous children relinquished to their fathers, custody status
of current baby undetermined/undocumented
3. Stage of recovery:
a. Adherent: Evidence of consistent use of medication-assisted therapy (methadone
or buprenorphine) in narrative documentation and toxicology screening
b. Relapsing: Evidence of use of illicit substances in addition to medication-assisted
therapy (methadone or buprenorphine) in narrative documentation and toxicology
screening
4. Definitions of acronyms:
a. SVD: spontaneous vaginal delivery
b. IUGR: intrauterine growth retardation
c. CS: Cesarean section
d. NICU: neonatal intensive care unit
e. CCN: continuing care nursery
f. MBU: postpartum mother-baby unit
g. FMRP: integrated care program where specialized substance use disorder
treatment, mental health, and social services are co-located within a perinatal care
practice
h. WCHM: prenatal practice that does not include specialized substance use disorder
treatment, mental health, and social services
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Appendix G: Data Analysis Process Flowchart

Familiarization

Thematic
framework

• Listened to recorded interviews for elements of speech
• Transcription of recorded data & fieldnotes
• Reviewed all transcribed data
• Reviewed artifacts
• Initial random coding

• Theoretical constructs extracted from literature
• Pre-fieldwork information considered

Indexing

• Coding themes created
• Transcribed & artifact data color-coded, placed within
themes
• Annotations & analytic memos

Charting

• Matrices developed for data retrieved from interview
transcripts, observational notes, & artifacts
• Verbatim text abstracted, synthesized, & summarized

Mapping &
interpreting

• Data matrices reviewed for themes & patterns
• Generated possible explanations, influenced by study aims
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